Bombesin-Induced Hypothermia at Normal Ambient Temperatures: Contribution of the Sympathetic Nervous System. by Barton, John Christopher
Louisiana State University
LSU Digital Commons
LSU Historical Dissertations and Theses Graduate School
1994
Bombesin-Induced Hypothermia at Normal
Ambient Temperatures: Contribution of the
Sympathetic Nervous System.
John Christopher Barton
Louisiana State University and Agricultural & Mechanical College
Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_disstheses
This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in
LSU Historical Dissertations and Theses by an authorized administrator of LSU Digital Commons. For more information, please contact
gradetd@lsu.edu.
Recommended Citation
Barton, John Christopher, "Bombesin-Induced Hypothermia at Normal Ambient Temperatures: Contribution of the Sympathetic
Nervous System." (1994). LSU Historical Dissertations and Theses. 5853.
https://digitalcommons.lsu.edu/gradschool_disstheses/5853
INFORMATION TO USERS
This manuscript has been reproduced from the microfilm master. UMI 
films the text directly from the original or copy submitted. Thus, some 
thesis and dissertation copies are in typewriter face, while others may 
be from any type of computer printer.
The quality of this reproduction is dependent upon the quality of the 
copy submitted. Broken or indistinct print, colored or poor quality 
illustrations and photographs, print bleedthrough, substandard margins, 
and improper alignment can adversely afreet reproduction.
In the unlikely event that the author did not send UMI a complete 
manuscript and there are missing pages, these will be noted. Also, if 
unauthorized copyright material had to be removed, a note will indicate 
the deletion.
Oversize materials (e.g., maps, drawings, charts) are reproduced by 
sectioning the original, beginning at the upper left-hand comer and 
continuing from left to right in equal sections with small overlaps. Each 
original is also photographed in one exposure and is included in 
reduced form at the back of the book.
Photographs included in the original manuscript have been reproduced 
xerographically in this copy. Higher quality 6" x 9" black and white 
photographic prints are available for any photographs or illustrations 
appearing in this copy for an additional charge. Contact UMI directly 
to order.
A Bell & Howell Information Company 
300 North Zeeb Road. Ann Arbor. Ml 48106-1346 USA 
313/761-4700 800/521-0600

BOMBESIN-INDUCED HYPOTHERMIA AT 
NORMAL AMBIENT TEMPERATURES: 
CONTRIBUTION OF THE SYMPATHETIC 
NERVOUS SYSTEM
A Dissertation
Submitted to the Graduate Faculty of the 
Louisiana State University and 
Agricultural and Mechanical College 
in partial fulfillment of the 
requirements for the degree of 
Doctor of Philosophy
in
The Department of Psychology
by
John Christopher Barton 
B.A., University of South Alabama, 1988 
M.S., University of South Alabama, 1990 
December 1994
UMI Number: 9524432
UMI Microform Edition 9524432 
Copyright 1995, by UMI Company. All rights reserved.
This microform edition is protected against unauthorized 
copying under Title 17, United States Code.
UMI
300 North Zeeb Road 
Ann Arbor, MI 48103
DEDICATION
There are several people to whom this work is 
dedicated. They have all contributed to my accomplishment 
of this goal.
First, my loving wife Cheryl. For over six years she 
has tolerated my status as a student, provided the vast 
majority of our financial support, moved no less than 7 
times and across several states, and has always selflessly 
given me moral support. Without my wife, there is no 
doubt in my mind that I couldn't have completed my efforts 
to pursue a doctoral degree. For all that she has done I 
shall be eternally indebted and grateful.
Second, my sweet daughter Erin, who has seen her 
father as a student for over half of her life. Thank you 
for all of the understanding during those years when I 
could not provide you with as much as I would have liked 
to, both in time and material goods.
Third, my former mentor Dr. Alex M. Babcock, who 
planted the seed of inquiry in my mind and fostered its 
growth. Thank you for the many times which you spent with 
me patiently trying to guide and teach me as I began my 
scientific training. You always treated me as an equal, 
and with respect and concern.
Last, but certainly not least, Dr. Claire D. Advokat. 
Thank you for your constant interest in my research and 
your perseverance in my support. You have provided a role
model for me, much in the manner that Dr. Babcock has in 
the past. You always had time to discuss and debate the 
scientific issues. You always made me feel that I could 
accomplish my goals.
ACKNOWLEDGMENTS
The author wishes to thank the following individuals 
for their valuable contributions toward completion of this 
work. I am gratefully indebted to my committee members, 
Paula J. Geiselman, Ph.D., Alan A. Baumeister, Ph.D., 
Claire D. Advokat, Ph.D., David A. York, Ph.D., and George 
A. Bray, M.D. Special recognition goes to Dr. Geiselman 
for serving as my Major Professor and Chair of my Final 
Examination Committee, her assistance in this matter is 
greatly appreciated.
Exceptional recognition goes to Drs. York and Bray 
for their guidance and fiscal support. They, through 
their instruction and direction, have greatly shaped my 
future in research and influenced me to be an analytical 
thinker. Additionally, they provided the heuristic 
nucleus for the growth of this project.
Special thanks is given to Mrs. Gail Bley, M.T., of 
the Clinical Chemistry Laboatory, Pennington Biomedical 





LIST OF TABLES....................................... vii




Isolation and Characterization of 
Bombesin.............................  1
2 DISTRIBUTION OF BOMBESIN-LIKE PEPTIDES  6
Peripheral Distribution..............  6
Central Distribution.................  7
Receptor Subtypes....................  9
3 PHYSIOLOGICAL ACTIONS OF BOMBESIN.........  15
Central Actions......................  15
Effect on the Autonomic Nervous
System..........................  15
Effect on the Gut...............  18
Endocrine Effects...............  20
Peripheral Actions of Bombesin.......  21
Effect on Smooth Muscle.........  21
Effect on the Gut...............  22
Endocrine Effects...............  23
Other Effects...................  25
4 BEHAVIORAL ACTIONS OF BOMBESIN  2 6
Effect of Central Bombesin on Feeding. 2 6
Effect of Peripheral Bombesin on
Feeding............................... 28
Effect of Bombesin on Drinking.......  32
Effect of Bombesin on Grooming and 
Locomotion...........................  34
5 BOMBESIN AND THERMOREGULATION.............  37
Introduction to Nonshivering
Thermogenesis........................  37
Bombesin in the Cold-Exposed Rat.....  41
Bombesin-Induced Hypothermia at Normal 
Ambient Temperatures.................  47
6 PROBLEM STATEMENT.......................... 53
Hypotheses...........................  56
v




Cannulae Verification................  60
Statistics...........................  61






















1. Matrix of Test Conditions; Experiment III.......  70
2. Core Body Temperature for Treatment Groups
Relative to Injection Time and Condition........  72
3 . Mean Serum Glucose Levels for Treatment Groups
Relative to Injection Time and Condition........  75
vii
LIST OF FIGURES
1. Amino acid sequence of selected
bombesin-like peptides..........................  3
2. Relation of permissive events to glucose
utilization and availability....................  52
3. Change in core temperature in ad libitum fed rats
treated with bombesin and chlorisondamine.......  64
4. Change in core temperature in ad libitum fed rats
following central bombesin and peripheral 
chlorisondamine and CL-316,243 ..................  67
5. Change in core temperature in acutely fasted rats
following central bombesin and
peripheral CL-316,243 ............................ 74
6. Change in core body temperature in acutely fasted
rats following central bombesin with and without 
adrenalectomy.................................... 7 9
7. Hypothesis that bombesin-induced hypothermia is
dependant on suppression of sympathetic nervous 
system activity.................................. 88
8. Theory of bombesin as an integrative peptide in
coregulation of temperature and feeding........  90
viii
ABSTRACT
Bombesin is a tetradecapeptide first isolated from frog 
skin. This peptide has potent effects on core body 
temperature of rats when administered centrally. 
Bombesin-induced hypothermia at normal ambient 
temperatures appears to be dependent upon some 
pre-existent condition which may be related to nutritional 
status. Four experiments were conducted to examine if the 
pre-existing condition for bombesin-induced hypothermia at 
normal ambient temperatures is primarily related to 
modulation of sympathetic nervous system activation. 
Experiment I demonstrated that central bombesin resulted 
in hypothermia in rats tested at normal ambient 
temperatures under conditions of ad-libitum access to food 
only when injected peripherally with the ganglionic 
blocker chlorisondamine. Experiment II demonstrated that 
bombesin-induced hypothermia in ad-libitum fed rats 
treated with chlorisondamine is prevented by peripheral
injection with the P3-adrenergic receptor agonist,
CL-316,243. Experiment III demonstrates that 
bombesin-induced hypothermia seen in acutely food-deprived 
rats is prevented by peripheral injection of CL-316,243. 
Experiment IV establishes that bombesin-induced 
hypothermia seen in acutely food-deprived rats is not 
dependent upon adrenal catecholamines and that peripheral
ix
corticosterone injection may promote hypothermia, possibly 
by suppression of corticotrophin-releasing hormone. The 
results are discussed in relation to sympathetic nervous 
system modulation and nutritional status.
x
INTRODUCTION 
Isolation and Characterization of Bombesin
A number of peptides that were first isolated in 
nonneural tissue have also been found in the central 
nervous system (Krieger, 1983). Many of these 
neuropeptides appear to function as neurotransmitters 
and/or neuromodulators (Krieger, 1983). A 
neurotransmitter is a substance, that when liberated from 
presynaptic terminals, will interact with receptors on a 
postsynaptic membrane of an adjacent cell (Krieger, 1983) . 
A neuromodulator represents a substance with nonclassical 
transmitter actions. It affects the actions of 
neurotransmitters by modifying their prototypical actions, 
for example, by blocking the release of specific 
transmitters or altering the synthesis and degradation of 
the transmitters (Krieger, 1983).
In 1970, Erspamer and coworkers isolated and 
characterized the tetradecapeptide bombesin from the skin 
of the European discoglossid frog Bowbina bombina 
(Erspamer, Erpamer, & Inselvini, 1970). This peptide is 
structurally similar to the peptide ranatensin (Geller, 
Govier, Pisano, Tanimura, & Van Clineschmidt, 1970; Van 
Clineschmidt, Geller, Govier, Pisano, & Tanimura, 1971). 
Both of these peptides have a general contractile type of 
activity on the majority of extravascular smooth muscle in 
mammals (Erspamer, Erspamer, Inselvini, & Negri, 1972).
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In 1971 a methodology for the synthesis of bombesin in the 
laboratory was reported (Bernardi, de Castiglione, 
Goffredo, & Angelucci, 1971). As research into isolation 
of bioactive peptides continued several other peptides 
were discovered that shared similar structure and 
biological activity with bombesin. In 1970, the isolation 
of the peptide alytesin from the skin of European 
discoglossid frog Alytes obstetricans was reported 
(Anastasi, Erspamer, & Bucci, 1971) . The amino acid 
sequence of bombesin and alytesin differ in only two 
positions, the second and sixth from the N-terminus 
(Anastasi, Erspamer, & Bucci, 1971). Additionally, the 
peptide neuromedin-B shares biological activity with 
bombesin (Minamino, Kangawa, & Matsuo, 1983) as does 
neuromedin-C (Minamino, Kangawa, & Matsuo, 1984) . These 
peptides, which were discovered to have similar amino acid 
sequence and share biological activity with bombesin, 
became known as bombesin-like peptides. The amino acid 
sequence of several of these bombesin-like peptides is 
depicted in Figure 1.
Research into the physiological effects of bombesin 
show that synthetic analogs of bombesin which have 
modifications of sequence near the N-terminal produce a 
reduction in receptor binding (Moody, Crawley, & Jensen, 
1982). Additional data demonstrated that the C-terminal 







Figure 1. Amino acid sequence of selected bombesin-like 
peptides.
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affinity binding and potent biological activity (Moody, 
Crawley, & Jensen, 1982). Other researchers have shown 
that bombesin-like peptides not containing tryptophan 
appear to have actions specific to the mammalian urinary 
bladder (Erspamer, 1988). The inclusion of tryptophan in 
the sequence of bombesin-like peptides is mandatory for 
the production of its effects on smooth muscle and the 
gastrointestinal tract (Erspamer, 1988). It was further 
established that in the bombesin subfamily of peptides, a 
minimum amino acid chain length of 9 is required for the 
full spectrum of bombesin-like activity on all type of 
smooth muscle preparations (Broccardo, Falconieri 
Erspamer, Melchiorri, Negri, & de Castiglione, 1975). The 
evidence that bombesin-like peptides with different amino 
acid structures act on separate tissues of the body 
suggests the existence of multiple bombesin receptor 
subtypes distributed in the periphery (Erspamer, 1988).
Gel chromatographic evidence indicates that true 
amphibian bombesin is not present in mammalian tissues 
(Walsh, Wong, & Dockray, 1979). In 1979 a mammalian 
counter part to bombesin was isolated from porcine gastric 
tissue (McDonald et al., 1979). This 27-amino acid 
peptide has an amino acid sequence similar to bombesin, 
and when administered peripherally, causes the release of 
gastrin. Thus this new peptide isolated in mammalian 
tissue became known as gastrin-releasing peptide (GRP).
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The carboxyl-terminal sequences of bombesin and GRP are 
identical in 9 of 10 amino acid residues (Reeve, Cuttitta, 
Vigna, Shively & Walsh, 1988). Gastrin releasing peptide 
is considered to be a mammalian analog of amphibian 
bombesin (Furness, Miller & Costa, 1988). While bombesin 
exerts biological activities which are similar to those of 
GRP, and the two are considered analogs, bombesin does not 
act as a gastrin releasing peptide in amphibians (van 
Wimersma Greidanus et al., 1984). It has been proposed 
that amphibian bombesin isolated from the skin of frogs of 
the Disscoglossid family does not function as a 
neurotransmitter or neuromodulator in amphibians and that 
its structural similarity with GRP is secondary to 
convergent evolution (van Wimersma Greidanus et al. ,
1984).
DISTRIBUTION OF BOMBESIN-LIKE PEPTIDES 
Peripheral Distribution
Bombesin-like immunoreactivity (BLI) in mammalian 
tissue is found in the greatest concentrations in the 
stomach (Furness, Miller & Costa, 1988). Significant 
concentrations of BLI are also found throughout the 
gastrointestinal tract and minor concentrations are found 
in the heart and lung (Brown, Allen, Villarreal, Rivier, & 
Vale, 1978). No detectable concentrations have been found 
in the adrenals, liver, kidney, pancreas, spleen, or 
skeletal muscles (Brown, Allen, Villarreal, Rivier, &
Vale, 1978). The BLI found in the stomach is localized 
within nerve cell bodies in the myenteric ganglia, muscle 
coats, and antral and nonantral regions of the gastric 
mucosa (Dockray, Vaillant, & Walsh, 1979; Tache, Brown, & 
Collu, 1979). There were few BLI ganglia found within the 
submucosa (Christensen & Rick, 1989). In the small 
intestine, immunoreactive cell bodies are encountered in 
the myenteric plexus, submucosal plexus, and myenteric 
ganglia (Dockray, Vaillant, & Walsh, 1979).
Immunoreactive ganglia are rare or absent within the 
mucosa of the small intestine (Furness, Miller & Costa,
1988). Within the large intestine of the rat and 
mouse, BLI fibers appear in the lamina propria of the 




High concentrations of BLI are found in the 
hypothalamus and pons/medulla areas (Panula, Yang, &
Costa, 1982). Additionally, bombesin-like immunoreactive 
cell bodies are found in the trigeminal complex and nuclei 
(Panula, Yang, & Costa, 1982), an area involved in 
regulation of autonomic functions. Bombesin-like 
immunoreactive cell bodies have also been found in the 
preoptic area of the hypothalamus, the ventral and medial 
parvocellular part of the paraventricular nucleus, and the 
suprachiasmatic nucleus (Pannula, Nieminen, Falkenberg & 
Auvinen, 1988) .
In the pons/medulla regions, bombesin-like activity 
has been detected in the laterodorsal tegmental nucleus, 
the nucleus of the solitary tract, and the parabrachial 
nucleus (Pannula, Nieminen, Falkenberg & Auvinen, 1988).
No detectable concentrations of BLI are found in the 
regions of the pituitary, pineal, or cerebellum (Brown, 
Allen, Villarreal, Rivier, & Vale, 1978; Walsh, Wong, & 
Dockray, 1979) .
Using autoradiography, high densities of 
bombesin-like receptors have been identified in the 
anterior olfactory nucleus accumbens, and olfactory 
tubercule (Moody, Getz, O'Donohue, & Rosenstein, 1988) . 
This method also revealed high densities within the 
central medial and paraventricular nuclei of the thalamus,
the paraventricular nuclei of the hypothalamus, the 
central and medial amygdaloid nuclei, and the dentate 
gyrus (Moody, Getz, O'Donohue, & Rosenstein, 1988; Wolf & 
Moody, 1985) . High densities of bombesin-like receptors 
are also found in the hippocampus (Pert, Moody, Pert, 
Dewald, & Rivier, 1980).
Moderate densities of receptors have been found in 
the internal granule layer of the olfactory bulb, frontal 
cortex of the forebrain, basal caudate putamen, rhinal 
cortex, rhinal neocortex, septohippicampal nucleus, bed 
nucleus of the stria terminalis, anterior hypothalamus, 
and medial preoptic nucleus (Moody, Getz, O'Donohue, & 
Rosenstein, 1988). The lowest densities were found in the 
cerebellum, medial forebrain bundle, lateral preoptic 
nucleus, and ventral pallidum areas of the anterior rat 
brain (Moody, Getz, O'Donohue, & Rosenstein, 1988). The 
lateral hypothalamus, and the ventromedial and dorsomedial 
hypothalamic nuclei also demonstrate low binding densities 
(Moody, Getz, O'Donohue, & Rosenstein, 1988). Within the 
midbrain, the central grey and reticular substantia nigra, 
superficial grey layer of the colliculus, and dorsal raphe 
nuclei have low densities of bombesin-like activity 
(Moody, Getz, O'Donohue, & Rosenstein, 1988).
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Receptor Subtypes
While GRP, neuromedin-B, and neuromedin-C belong to 
the same family of bombesin-like peptides, they display 
significant differences in sequence homology.
Neuromedin-C and GRP share the carboxyl-terminal 
heptapeptide sequence, which is the biologically active 
segment of these peptides, with amphibian bombesin 
(Minamino, Kangawa, & Matsuo, 1984; Minamino, Kangawa, & 
Matsuo, 1983). In contrast, neuromedin-B appears to share 
a much closer sequence homology with the amphibian 
oligopeptide litorin (Minamino, Kangawa, & Matsuo, 1984; 
Minamino, Kangawa, & Matsuo, 1983). These findings have 
been suggested to constitute a basis for the possible 
existence of multiple bombesin receptor types (Von 
Schrenck et al., 1989).
Using autoradiography, it has been shown that two 
different receptor sites for bombesin-like peptides exists 
in the periphery (Von Schrenck et al., 1989).
Radio-labeled bombesin was found to bind with receptors in 
both the esophagus and pancreas while radio-labeled 
neuromedin-B bound only with the epithehial cells of the 
esophagus (Von Schrenck et al., 1989). In each of these 
tissue types, binding of the radio-labled peptides was 
saturable, dependent on pH, time, and temperature, as well 
as being reversible and specific (Von Schrenck et al., 
1989). In the esophagus the relative potencies for
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inhibition of binding of both tracers illustrated that 
neuromedin-B bound more strongly than bombesin and GRP 
(Von Schrenck et al., 1989). In the pancreatic tissue 
assays, bombesin and GRP bound more potently than 
neuromedin-B (Von Schrenck et al., 1989). Computer 
analysis of the binding sites revealed that a single 
binding site existed in assays of each tissue, and that 
differences in binding between tissues and peptide could 
only be explained by way of at least two subtypes of 
bombesin receptors in the periphery (Von Schrenck et al. ,
1989). There is a heterogeneity of bombesin receptor 
sites in the rat central nervous system. The rat cerebral 
cortex appears to contain many more neuromedin-B receptors 
than bombesin/GRP receptors (Ladenheim, Jensen, Mantey, 
McHugh, & Moran, 1990). In the nucleus accumbens, 
neuromedin-B was less effective at inhibiting binding of 
radio-labeled bombesin, suggesting that this area is more 
sensitive to binding by bombesin (Ladenheim, Jensen, 
Mantey, McHugh, & Moran, 1990). In assays of the nucleus 
of the solitary tract, it appears that neuromedin-B binds 
with much greater affinity to receptors than does bombesin 
(Ladenheim, Jensen, Mantey, McHugh, & Moran, 1990).
Using an in vitro autoradiographic methodology, 
Ladenheim and coworkers have isolated two distinct 
bombesin receptor subtypes in the rat central nervous 
system which correspond to bombesin/GRP and neuromedin-B
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(Ladenheim, Jensen, Mantey, & Moran, 1992) . In examining 
the differentiation of binding patterns, it was discovered 
that three general distributions of bombesin-like peptide 
binding exist. One distinct pattern of binding is 
referred to as bombesin/GRP-preffering, and is comprised 
of the supraoptic nucleus, paraventricular nucleus, the 
arcuate nucleus, and the outer rim of the hippocampal 
oriens layer (Ladenheim, Jensen, Mantey, & Moran, 1992).
A second pattern, which has been designated as 
neuromedin-B preferring includes the thalamus, dentate 
gyrus, and ventromedial hypothalamus (Ladenheim, Jensen, 
Mantey, & Moran, 1992) . A third pattern of binding was 
discovered in the spinal trigeminal tract in the caudal 
hindbrain, in which both bombesin/GRP preferring and 
neuromedin-B preferring patterns were found (Ladenheim, 
Jensen, Mantey, & Moran, 1992).
Examination of regional distributions of bombesin and 
neuromedin-B demonstrates high densities of neuromedin-B 
preferring binding sites located in the olfactory bulb and 
anterior olfactory nucleus, amygdalopyriform transition, 
amygdalohippocampal area, and lateral amygdala (Ladenheim, 
Jensen, Mantey, & Moran, 1992). Moderate densities of 
neuromedin-B binding are found in the ventromedial 
hypothalamic nucleus, stria terminalis, and medial 
mammillary nucleus (Ladenheim, Jensen, Mantey, & Moran, 
1992). The lowest densities of neuromedin-B
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immunoreactivity are found in the infundibular stem, tuber 
cinereum, and caudate (Ladenheim, Jensen, Mantey, & Moran,
1992). In the thalamic areas, neuromedin-B exhibits high 
densities in the paraventricular and posteromedian nuclei, 
moderate densities in the central median, rhomboid, 
reuniens, and intermediodorsal nuclei (Ladenheim, Jensen, 
Mantey, & Moran, 1992). Interestingly, there are no 
thalamic nuclei that contained bombesin/GRP preferring 
binding sites (Ladenheim, Jensen, Mantey, & Moran, 1992).
In the anterior forebrain regions, bombesin/GRP 
preferring binding sites are mainly located in the 
hippocampus, with high densities in the magnocellular 
region of the paraventricular nucleus, arcuate, 
suprachiasmatic nuclei, and lateral mammillary bodies 
(Ladenheim, Jensen, Mantey, & Moran, 1992). Additional 
high density sites are found in the lateral and ventral 
aspects of the bed nucleus of the stria terminalis and the 
outer edge of the hippocampal oreins (Ladenheim, Jensen, 
Mantey, & Moran, 1992) . Moderate densities of 
bombesin/GRP-preferring sites are located in the molecular 
layer of the hippocampus, and layers I-VI of the cortex 
with the greatest densities in the parietal cortex 
(Ladenheim, Jensen, Mantey, & Moran, 1992).
In the midbrain, moderate levels of 
bombesin/GRP-preferring densities were found in the 
reticular subdivision of the substantia nigra, and low
13
levels of binding in the ventral tegmental region 
(Ladenheim, Jensen, Mantey, & Moran, 1992). Moderate 
levels of neuromedin-B preferring binding sites were found 
in the dorsal raphe, median raphe, and pontine nuclei 
while the lateral and dorsomedial interpenduncular nucleus 
exhibited high binding densities (Ladenheim, Jensen, 
Mantey, & Moran, 1992). Low levels of bombesin/GRP 
preferring binding densities was found in the ventral 
tegmental region, while low levels of neuromedin-B 
preferring densities were identified in the dorsal cortex 
of the inferior colliculus (Ladenheim, Jensen, Mantey, & 
Moran, 19 92) .
In the hindbrain moderate densities of neuromedin-B 
preferring binding sites were located in the lateral and 
medial parabrachial nuclei, locus coeruleus, prepositus 
hypoglossal nuclei, nucleus of the solitary tract, and the 
periventricular grey of the dorsal rim of the fourth 
ventricle (Ladenheim, Jensen, Mantey, & Moran, 1992).
High densities of bombesin/GRP preferring binding sites 
were observed in the spinal trigeminal nucleus and nucleus 
ambiguus, while moderate densities were seen in the 
gigantocellular reticular nucleus (Ladenheim, Jensen, 
Mantey, & Moran, 1992) . The lowest densities of 
bombesin/GRP preferring binding sites were observed in the 
inferior olivary nucleus (Ladenheim, Jensen, Mantey, & 
Moran, 1992).
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Studies performed using bombesin receptor antagonists 
have demonstrated similar distributions of receptor 
subtypes in the central nervous system (Ladenheim et al.,
1993) and the periphery (Von Schrenck et al., 1990). 
Clearly there is a wide spread distribution of at least 
two known bombesin receptor subtypes both in the central 
nervous and in peripheral tissues, specifically the 
gastrointestinal tract.
PHYSIOLOGICAL ACTIONS OF BOMBESIN 
Central Actions 
Effect on the Autonomic Nervous System
Central administration of bombesin-like peptides 
produces a variety of changes in autonomic nervous system 
substrata. Injection of bombesin into the intracerebral 
ventricles (icv) produces a significant increase in plasma 
levels of norepinephrine and epinephrine in the rat 
(Brown, Carver & Fisher, 1988). Centrally administered 
bombesin has a markedly greater potential to induce 
elevations in plasma epinephrine levels relative to 
norepinephrine (Brown & Fisher, 1984). Bilateral 
adrenalectomy abolishes the increase in epinephrine that 
follows central administration, suggesting that bombesin 
stimulates brain regions which have neural influence on 
the adrenal glands (Brown & Fisher, 1984; Brown, Tache, & 
Fisher, 1979; Fisher & Brown, 1984). The specific brain 
region/s through which bombesin exerts its influence on 
norepinephrine levels have not been located, but may be 
the same site at which it regulates epinephrine levels, 
which is the rostral aspect of the nucleus of the solitary 
tract (Brown, Tache, & Fisher, 1979). It is possible that 
the brain site(s) responsible for this effect may be 
anterior to, or project neural pathways through, the 
lateral hypothalamus since lesions of the lateral 
hypothalamus, or transections lateral or posterior to it
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attenuate bombesin-induced elevations of glucose found 
secondary to adrenal stimulation (Gunion, Grijalva, Tache, 
& Novin, 1984).
The stimulation bombesin exerts on the adrenal 
medulla appears to be mediated by neural rather than 
humoral events (Brown, 1981; Brown & Fisher, 1984; Brown, 
Tache, & Fisher, 1979; Somiya Sc Tonoue, 1984). Central 
injection of bombesin has been demonstrated to increase 
adrenal epinephrine secretion, inhibit gastric acid 
secretion, and elevate heart rate and blood pressure via 
sympathetic nervous system mediation (Brown Sc Tache,
1981). In addition to adrenal modulation of metabolic 
fuels, bombesin has been observed to significantly 
suppress both vagal and sympathetic outflow to the stomach 
while markedly stimulating activity in the laryngeal 
branch of the vagus and the adrenal sympathetic nerve 
(Somiya Sc Tonoue, 1984).
Bombesin has also been shown to have potent effects 
on other parameters of autonomic function. Injections of 
bombesin into the lateral ventricles of rats results in a 
reduction of the normal rise in heart rate and oxygen 
consumption secondary to exposure to cold which may be 
secondary to modification of a central mechanism 
controlling cardiac function (Fisher, Cave, Sc Brown,
1985). Additional research in this area illustrates that 
central administration of bombesin produces elevations in
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mean arterial pressure, heart rate, and suppresses 
cold-induced tachycardia (Fisher Sc Brown, 1984). Only the 
elevation in mean arterial pressure seen after bombesin 
administration is attenuated by adrenalectomy (Fisher & 
Brown, 1984), suggesting that the other changes seen were 
secondary to neural rather than humoral mechanisms.
Central bombesin has also been found to modulate 
respiratory function. Bombesin icv produces elevations in 
minute volumes in rats which are secondary to an overall 
increase in respiratory rate and tidal volume, as well as 
significant increases in sighing respiration (Niewoehner, 
Levine, & Morley, 1983).
Rats treated with bombesin centrally do not exhibit 
cold-induced accumulation of dopamine in the interscapular
brown fat of rats treated with a dopamine (3-hydroxylase
inhibitor (Brown, Allen, & Fisher, 1987). This finding 
suggests that bombesin inhibits cold-induced sympathetic 
outflow to brown fat. This inhibition of dopamine 
accumulation in brown fat in cold-exposed animals was 
found to be a viscerotopically specific response, as 
dopamine levels in other tissues were not effected (Brown, 
Allen, Sc Fisher, 1987) . Others have reported that animals 
tested with bombesin at normal ambient temperatures 
exhibit reduced interscapular brown fat thermogenesis 
relative to core body temperatures (Shido, Noda, & 
Nagasaka, 1987).
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Effect on the Gut
Central bombesin decreases both volume and 
concentration of gastric secretions in conscious, 
pylorus-ligated rats (Tache, Vale, Rivier, & Brown, 1980). 
This effect is dose dependent, long lasting, and 
reversible. Bombesin injected into the cisterna magna 
produces potent increases in mucus secretion from the 
gastric wall in rats, which is of long duration (Tache, 
Vale, Rivier, & Brown, 1980). Intraventricular bombesin 
produces a dose dependent inhibition of gastric emptying 
and small intestine motility, while producing a transient 
stimulation of, large intestine motility (Porreca & Burks, 
1983; Porreca, Burks, & Koslo, 1985; Tache, Brown, &
Collu, 1979) and duodenal contraction frequency (Porreca, 
Burks, & Koslo, 1985). This effect appears to be mediated 
by a disruption of normal peristaltic activity, rather 
than a simple reduction in wave frequency since various 
areas of the gastrointestinal tract are affected 
differently. The inhibition of gastric emptying seen in 
rats receiving central bombesin is abolished by vagotomy 
(Porreca & Burks, 1983).
A large number of studies have established the potent 
ability of bombesin to inhibit gastric acid secretion 
after central administration (Brown & Tache, 1981; Gunion, 
Tache, Walsh, & Novin, 1984; Tache, 1985; Tache, Lesiege,
& Goto, 1986; Tache, Vale, Rivier, & Brown, 1980; Tache,
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Vale, Rivier, & Brown, 1981; Yang, Cuttitta, Raybould, & 
Tache, 1989). Reports indicate that bombesin injected 
into the lateral ventricles (Brown & Tache, 1981; Gunion, 
Tache, Walsh, & Novin, 1984; Tache, 1985; Tache, Lesiege, 
& Goto, 1986; Tache, Vale, Rivier, & Brown, 1980; Tache, 
Vale, Rivier, & Brown, 1981) or administered intrathecally 
(Yang, Cuttitta, Raybould, & Tache, 1989), reliably 
suppresses gastric acid secretion in rats. This reduction 
in gastric acid secretion results in a general increase in 
gastric pH, and is not attenuated by abdominal vagotomy 
(Tache, Lesiege, & Goto, 1986), nor do prostaglandin or 
opioid pathways mediate this activity (Tache, 1985) . 
Lesions of the ventromedial hypothalamus do not attenuate 
bombesin-induced reductions in acid secretion (Gunion, 
Tache, Walsh, & Novin, 1984). Interestingly, 
intracisternal injection of bombesin produces a long 
lasting and robust increase in serum gastrin levels 
(Tache, Marki, Rivier, Vale, & Brown, 1981; Tache, Vale, 
Rivier, & Brown, 1980). It has been reasoned that 
bombesin inhibits the acid secretory effect of endogenous 
gastrin by elevating gastric pH. It has also been 
suggested that bombesin produces changes in gastric acid 
secretion by excitation of the sympatho-adrenomedullary 
system (Okuma, Yokotani, & Osumi, 1987). The exact 




Central bombesin has been found to modulate the 
secretion of a wide variety of endocrine products.
Bombesin injection into the central nervous system 
increases serum glucose, free fatty acids, and 
corticosterone levels (Babcock, Barton, Gunion, & 
Rosenthal, 1992; Gunion et al., 1989). The ability of 
central administration of bombesin to induce hyperglycemia 
has been well established (Brown, Tache, & Fisher, 1979; 
Gunion, Grijalva, Tache, & Novin, 1984; Brown, 1981).
This effect appears to be mediated by bombesin-induced 
stimulation of epinephrine from the adrenal medulla 
(Brown, Tache, & Fisher, 1979). Adrenalectomy, but not 
hypophysectomy prevents bombesin-induced hyperglycemia, 
further supporting the role of the adrenals in this event 
(Brown, Tache, & Fisher, 1979). In addition to inducing 
hyperglycemia, central administration of bombesin results 
in elevations of serum epinephrine (Brown & Fisher, 1984), 
hyperglucagonemia, and relative hypoinsulinemia, with 
insignificant effect on dopamine or norepinephrine (Brown, 
1981; Brown, Tache, & Fisher, 1979). Brown has suggested 
that bombesin-induced changes seen in glucose, glucagon, 
and insulin levels are secondary to the release of adrenal 
epinephrine (Brown, 1981). Additionally, it has been 
demonstrated that lesions of the lateral hypothalamus or 
transections of the lateral or posterior borders of the
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lateral hypothalamus block bombesin-induced hyperglycemia 
(Gunion, Grijalva, Tache, & Novin, 1984) . These findings 
would suggest that bombesin produces these effects by 
acting on brain sites which are adjacent to, or project 
neural efferents through, the lateral hypothalamus.
Bombesin also inhibits stress-induced elevations in 
prolactin while having no effect on corticosterone, growth 
hormone, or lutenizing hormone in one study (Tache, Brown, 
& Collu, 1979), while others have demonstrated that 
gastrin-releasing peptide suppresses growth hormone 
secretion (Pinski et al., 1992), and bombesin elevates 
serum corticosterone levels (Babcock, Barton, Gunion, & 
Rosenthal, 1992; Gunion et al., 1989). The disparity 
between these findings may be related to the fact that in 
the stressed animals these hormone levels could have been 
maximally stimulated, and thereby resistant to the effects 
of bombesin.
Peripheral Actions of Bombesin 
Effect on Smooth Muscle
When administered peripherally, bombesin has a potent 
effect on smooth muscle including the intestine, blood 
vessels, urinary bladder, and uterus (Erspamer, Erpamer, & 
Inselvini, 1970; Erspamer, Erspamer, Inselvini, & Negri, 
1972). These effects vary between species; dogs, cats, 
rabbits, and rats experience an increase in blood pressure
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and smooth muscle tone, while primates experience a 
decrease in blood pressure (Erspamer, Erspamer, Inselvini, 
& Negri, 1972). Additionally, intravenous administration 
of bombesin produces dose-dependent increases in mean 
arterial pressure and heart rate in rats (Bayorh & 
Feuerstein, 1985).
Effect on the Gut
Bombesin injected either subcutaneously or 
intravenously stimulates secretion of gastric acid as well 
as pepsin from the fundus of denervated stomach in the dog 
(Bertaccini, Erspamer, & Impicciatore, 1973). Bombesin 
alters gastric motility in rats, dogs, and man. In the 
rat, bombesin induces spasmogenic activity independent of 
the autonomic nervous system (Bertaccini & Impicciatore, 
1975). In man, bombesin exerts a contractile effect on 
the antrum and the pylorus while having an inhibitory 
effect on motility on the stomach body and the fundus 
(Bertaccini & Impicciatore, 1975). While bombesin has 
potent effects on the motility of the stomach tissue, 
there is no effect of bombesin on gastric emptying 
(Hostetler, McHugh, & Moran, 1989). Additionally, 
bombesin has been demonstrated to have potent stimulatory 




Bombesin has been found to produce several changes in 
endocrine function when administered peripherally. 
Intravenous bombesin injections into food-deprived baboons 
produces an elevation of plasma insulin levels without 
changing plasma glucose (Woods, Stein, Figlewicz, & Porte, 
Jr., 1983). When animals are allowed to feed after 
bombesin injection there is a reduction in plasma insulin 
after completion of the feeding interval (Woods, Stein, 
Figlewicz, & Porte, Jr., 1983). In addition, 
intravenous administration of bombesin increases plasma 
glucagon levels in the dog (Kaneto, Kaneko, Nakaya, 
Kajinuma, & Kosaka, 1978; Vaysse et al., 1981) and 
suppresses the post-prandial rise in serum glucose (Woods, 
Stein, Figlewicz, & Porte, Jr., 1983).
It appears that bombesin exerts a potent effect on 
pancreatic tissues. In dogs, systemic administration of 
bombesin produces an increase in pancreatic polypeptide in 
a fashion similar to ingestion of a meal of meat 
(Konturek, Konturek, Bielanski, & Szewczyk, 1989). This 
increase in pancreatic polypeptide can be blocked by the 
cholecystokinin antagonist, L-364,718 (Konturek, Konturek, 
Bielanski, & Szewczyk, 1989). This would suggest that 
bombesin produces this effect via activation of endogenous 
cholecystokinin. Treatment of pancreatic tissue with 
bombesin results in increased amylase release (Lee,
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Jensen, & Gardner, 1980), which can be blocked with a 
bombesin antagonist (Sekar, Uemura, Coy, Hirschowitz, & 
Dickinson, 1991). These results have been replicated in 
conscious rats with chronic pancreatic fistula (Jaworek, 
Konturek, Konturek, Cai, & Schally, 1992). Bombesin 
stimulates a rapid increase in the concentration of free 
cytosolic calcium ions which is believed to be, in part, 
responsible for bombesin effect on stimulation of 
pancreatic enzymes (Pandol & Mendius, 1988).
In isolated tissue preparations, bombesin has been 
shown to stimulate somatostatin release as well as gastrin 
(DuVal et al., 1981). In conscious dogs, intravenous 
bombesin increases somatostatin-like immunoreactivity, 
which can be partially attenuated by administration of 
atropine sulfate (De Graef & Woussen-Colle, 1985) 
implicating, at least in part, a cholinergic mechanism.
The increase in gastrin release by bombesin in isolated 
tissue (Azuma, Taggart, & Walsh, 1987; DuVal et al., 1981) 
has also been reproduced in dogs (Bertaccini, Erspamer, 
Melchiorri, & Sopranzi, 1974). In addition to its other 
endocrine effects, bombesin has been found to regulate the 
release of cholecystokinin from the small intestine 
(Bertaccini, Erspamer, & Impicciatore, 1973) and stimulate 
the release of prostaglandins from isolated rabbit ear 




Bombesin administered peripherally enhances memory 
retention in rats (Flood & Morley, 1988). This is 
attenuated by vagotomy, suggesting that an ascending vagal 
pathway participates in this event (Flood & Morley, 1988). 
This finding is similar to those of previous reports which 
implicate feeding in the enhancement of memory and 
suggests that this event is not specifically due to 
feeding, but is reliant on the stimulation of 
gastrointestinal peptides by food intake. Peripheral 
bombesin treatment also enhances slow wave sleep (de Saint 
Hilaire-Kafi, Gibbs, & Nicolaidis, 1989).
Bombesin has been found to produce other changes 
after peripheral administration. Intraperitoneal 
injection of bombesin in rats increases metabolism, as 
measured by computerized open circuit respirometer (Even, 
de Saint Hilaire, & Nicolaidis, 1991). The existence of 
bombesin in the periphery has also been linked with 
several types of neoplasms, and is believed to act as a 
growth factor in these tissues (Wiedermann, Ruff, & Pert, 
1988). Included in these neoplasms are testicular cancer 
(Fathi et al., 1993), small cell lung carcinoma (Kane et 
al., 1991; Wiedermann, 1989), and glioblastoma (Wang et 
al., 1992).
BEHAVIORAL ACTIONS OF BOMBESIN 
Effect of Central Bombesin on Feeding
Administration of bombesin produces a reduction in 
food intake under a variety of paradigms (Avery &
Calisher, 1982; Babcock, Avery, & Maitland, 1985; Babcock 
& Barton, 1990; Babcock, Barton, Gunion, & Rosenthal,
1992; Babcock, Barton, Perez, & Hearndon, 1989; Barton & 
Babcock, 1990; Calisher & Avery, 1984; Gibbs, Kulkosky, & 
Smith, 1981; Kulkosky, 1988; Kulkosky, Gibbs, & Smith, 
1982; Ladenheim & Ritter, 1988; Merali et al., 1988; 
Merali, Moody, & Coy, 1993; Oku, Inoue, Glick, Bray, & 
Walsh, 1984; Stuckey & Gibbs, 1982). Specifically, 
intraventricular bombesin suppresses feeding in acutely 
deprived rats allowed food access after bombesin treatment 
(Avery & Calisher, 1982; Babcock, Avery, & Maitland, 1985; 
Babcock, Barton, Perez, & Hearndon, 1989; Barton &
Babcock, 1990; Gibbs, Kulkosky, & Smith, 1981; Kulkosky, 
1988; Kulkosky, Gibbs, & Smith, 1982; Ladenheim & Ritter, 
1988). Bombesin has also been established to inhibit 
feeding when injected into individual brain regions. 
Bombesin injection into the lateral hypothalamus (Stuckey 
& Gibbs, 1982), substantia nigra (Calisher & Avery, 1984), 
preoptic area of the hypothalamus (Babcock, Barton,
Gunion, Sc Rosenthal, 1992), and hypothalamic 
paraventricular nucleus (Babcock Sc Barton, 1990) produces 
significant reductions in food intake. In multiple
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studies, central injections of bombesin have been found to 
suppress operant responding for both food and water 
(Babcock, Avery, & Maitland, 1985; Gibbs, Kulkosky, & 
Smith, 1981; Kulkosky, Gibbs, & Smith, 1982), while in 
others it was found to be specific to food reward (Avery & 
Calisher, 1982; Stuckey & Gibbs, 1982). These findings 
have brought some researchers to the belief that bombesin 
may act as a potential aversive agent when administered 
centrally. Kulkosky and colleagues (Kulkosky, Gibbs, & 
Smith, 1982) reported an increase in grooming after 
central doses of bombesin which suppress food intake. Yet 
other behaviors common to feeding, but not specific 
parameters of consumption, such as chewing, are not 
altered by intraventricular injections of bombesin 
(Morley, Levine, Murray, Knelp, & Grace, 1982) . Other 
data would lend additional support to the belief that 
bombesin does not create an aversive state when 
administered centrally. Bombesin does not produce a 
conditioned taste aversion at doses which have been 
reported to suppress food intake (Kulkosky, Gray, Gibbs, & 
Smith, 1981). Additionally, low doses of bombesin which 
suppress feeding induce changes in grooming and locomotion 
closely related to those seen under conditions of normal 
satiety (McCoy & Avery, 1990). The most convincing 
evidence to support the hypothesis that central bombesin 
may act as a satiety agent comes from findings that very
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low doses into the fourth ventricle produce reductions in 
feeding with no increase in grooming or locomotion 
(Ladenheim & Ritter, 1988), that increases in 
bombesin-like peptide activity in the hypothalamus and 
hippocampus occur after feeding (Kateb & Merali, 1992), 
and that newly developed bombesin receptor antagonists 
injected centrally result in increase food intake (Merali, 
Moody, & Coy, 1993). Thus, evidence exists suggesting 
that bombesin may mimic a possible satiety action of 
gastrin-releasing peptide by acting on central receptor 
sites, and that while having potent anorectic effects in a 
variety of brain regions, specific changes in behavior 
related to reductions in feeding and potential satiety may 
be controlled by periventricular areas. One theory that 
has been forwarded, is that bombesin acts both within the 
central nervous system and periphery to integrate events 
associated with regulation of food intake, development of 
satiety, and satiety related behaviors (McCoy & Avery,
1990).
Effect of Peripheral Bombesin on Feeding
Unlike the case with central bombesin injections, 
there appears to be a much greater agreement among 
researchers that peripheral administration of bombesin 
produces satiety without aversion or malaise (McCoy & 
Avery, 1990). Peripheral administration of bombesin
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inhibits food intake in food-deprived rats (Flood, Silver, 
& Morley, 1990; Gibbs, 1985; Gibbs et al., 1979; Gibbs, 
Kulkosky, & Smith, 1981; Gibbs & Smith, 1982; Hostetler, 
McHugh, & Moran, 1989; Kulkosky & Gibbs, 1982; Kulkosky, 
Gibbs, & Smith, 1982; Kulkosky, Gray, Gibbs, & Smith,
1981; Wager-Srdar, Morley, & Levine, 1986), rats with 
lesions of the ventromedial hypothalamus (Geary, Smith, & 
Gibbs, 1986), rats induced to eat by opioids (Morley, 
Levine, Kneip, Grace, & Billington, 1983), or acute stress 
(Morley & Levine, 1981),as well as in mice (Silver, Flood, 
& Morley, 1988), hamsters (Miceli & Malsbury, 1985), wolf 
pups (Morley, Levine, Hertel, Tandeski, & Seal, 1986), 
baboons (Woods, Stein, Figlewicz, & Porte, Jr., 1983), 
dogs (Levine, Sievert, Morley, Gosnell, & Silvis, 1984), 
and humans (Muurahainen, Kissileff, Thornton, & Pi-Sunyer,
1983). While Deutsch has asserted that bombesin may 
produce satiety via production of aversion (Deutsch & 
Parsons, 1981), there is evidence against this suggestion.
Research has revealed a fixed sequence of 
behaviors which are characteristic of satiety in the rat 
(Antin, Gibbs, Holt, Young, & Smith, 1975). These 
behavioral parameters are: Termination of feeding, short 
term grooming and exploration, followed by rest or sleep 
(Antin, Gibbs, Holt, Young, & Smith, 1975). Peripheral 
administration of bombesin elicits a sequence of events 
associated with normal satiety such as, grooming,
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sniffing, locomotion, and rearing, followed by withdrawal 
from the site of feeding and rest or sleep (Gibbs, 1985; 
Gibbs, Kulkosky, & Smith, 1981). Additionally, bombesin 
reduces operant responding for food as a reward (Babcock, 
Avery, & Maitland, 1985; Flood, Silver, & Morley, 1990), 
indicating a reduction of hunger. Peripherally 
administered bombesin is equally potent at suppressing 
both liquid and solid meals (Gibbs et al., 1979), while 
not suppressing intake of water (Kulkosky, Gibbs, & Smith, 
1982; Kulkosky, Gray, Gibbs, & Smith, 1981). The 
suppression of feeding observed after peripheral bombesin 
administration is not due to changes in gastric emptying 
(Gibbs & Smith, 1986; Hostetler, McHugh, & Moran, 1989), 
and does not require vagal innervation of the stomach to 
produce these effects (Gibbs & Smith, 1986; Morley,
Levine, Kneip, & Grace, 1982; Smith, Jerome, & Gibbs, 
1981). Added evidence for peripheral bombesin as a 
satiety agent are the findings that it elicits satiety in 
sham fed rats (Martin & Gibbs, 1980), and that it does not 
produce a conditioned taste aversion (Kulkosky, Gray, 
Gibbs, & Smith, 1981). There is additional evidence that 
suggests bombesin suppresses food intake independent of 
peripheral release of cholycystokinin (Gibbs & Smith,
1986). While the exact site through which peripheral 
bombesin produces satiety is unknown, there is data to 
suggest that it acts on receptors in the gut to modulate
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feeding. Bombesin-like immunoreactivity has been well 
demonstrated in the gastrointestinal tract (Brown, Allen, 
Villarreal, Rivier, & Vale, 1978). Perfusion of the 
celiac artery with bombesin produces suppression of 
feeding more so than perfusion of the superior mesenteric 
artery, or when injected intraperitoneally (Kirkham,
Gibbs, & Smith, 1991) . Since the celiac arterial blood 
supply perfuses the stomach, pancreas, liver, spleen, and 
proximal duodenum, it would seem likely that one or more 
of these organs may provide a primary site of bombesin 
action on feeding in the periphery. While the vagal 
innervation of the stomach is not necessary for bombesin 
to produce reduction in feeding, there is evidence for a 
gut brain axis of action. Complete neural disconnection 
of the gut from the brain blocks bombesin-induced satiety 
(Stuckey, Gibbs, & Smith, 1985) and peripheral treatment 
with capsaicin, a neurotoxin known to destroy small 
diameter sensory neurons, attenuates bombesin-induced 
suppression of feeding (Ladenheim & Ritter, 1991).
One way bombesin may produce reductions in feeding is 
by modulating sympathetic activity. Many peptides which 
modulate food intake do so in a reciprocal relationship to 
their effects on sympathetic nervous system activity 
(Bray, 1993). Bray has suggested that peptides that 
attenuate feeding may do so by increasing sympathetic 
activity (Bray, 1992). The exact mechanism by which
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bombesin may modulate sympathetic activity is unclear. 
Adrenalectomy abolishes obesity in a variety of 
experimental paradigms (Tokunaga et al., 1989; Holt &
York, 1989), and glucocorticoids have been shown to be 
necessary components of overeating and obesity (Brown & 
Fisher, 1986). It appears that adrenalectomy increases 
sympathetic activity by removing negative feedback 
modulation of corticotrophin-releasing hormone, thus 
reversing over consumption and obesity (Vander Tuig, 
Ohshima, Yoshida, Romsos, & Bray, 1984). While 
adrenalectomy attenuates some of the behavioral effects of 
bombesin (Hawkins & Avery, 1983), and peripheral bombesin 
stimulates adrenal function (Brown, Tache, & Fisher, 1979; 
Okuma, Yokotani, & Osumi, 1987), the adrenal glands are 
not necessary for bombesin-induced suppression of feeding 
(Gibbs, Kulkosky, & Smith, 1981), indicating an 
extra-adrenal site for possible peripheral bombesin 
modulation of sympathetic activity.
Effect of Bombesin on Drinking
Central bombesin administration has been demonstrated 
to suppress drinking in rats at doses that are 
insufficient to attenuate feeding (Kulkosky, Gibbs, & 
Smith, 1982). In fact, the majority of reports of 
investigation of intraventricular bombesin administration 
on drinking reveals that, with the exception of one
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(Ladenheim & Ritter, 1988), all tested paradigms have 
consistently demonstrated bombesin-induced reductions of 
water consumption (Babcock, Avery, & Maitland, 1985; de 
Caro, Massi, Micossi, & Perfumi, 1984; Gibbs, Kulkosky, & 
Smith, 1981; Kulkosky, Gibbs, & Smith, 1982; Miceli & 
Malsbury, 1985). Additional evidence has shown that site 
specific microinjections of bombesin into the lateral 
hypothalamus, nucleus caudatus putamen, and olfactory 
tubercle suppress drinking (Willis, Hansky, & Smith,
1984), while others have demonstrated findings contrary to 
these (Stuckey & Gibbs, 1982). Clearly the preponderance 
of evidence implicates central administration of bombesin 
in reduction of drinking behavior. As reported in 
examining the central effects of bombesin on feeding, the 
primary explanation for this reduction in drinking is 
attributed to marked increases in grooming and other 
competitive behaviors (Miceli & Malsbury, 1985). The 
exact mechanism by which central bombesin exerts this 
suppression of drinking remains unknown, but may be 
related to potential aversive effects.
Findings with peripheral administration of bombesin 
stand in contrast to those under central administration.
In experiments designed to examine the effects of bombesin 
on feeding and drinking behavior, peripheral 
administration of bombesin at doses which were 
demonstrated to suppress feeding failed to alter drinking
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(Kulkosky, Gibbs, & Smith, 1982; Kulkosky, Gray, Gibbs, & 
Smith, 1981; Miceli & Malsbury, 1985). To date, there are 
no published reports of peripheral bombesin administration 
resulting in reductions of water consumption.
Effect of Bombesin on Grooming and Locomotion
Rats given bombesin centrally typically display a set 
of stereotypies which include: forepaw tremors, "wet-dog" 
shakes, and excessive grooming (Brown, Rivier, & Vale, 
1977). The excessive grooming behavior is characterized 
by scratching of the head and neck with both forepaw and 
hindpaw, as well as bathing with saliva. Kulkosky has 
suggested that bombesin may act as an afferent 
somatosensory neurotransmitter, and that grooming produced 
by central administration of bombesin may reflect a 
response to alteration of cutaneous sensation (Kulkosky, 
1988). This increased grooming following central bombesin 
is also associated with the suppression of feeding seen 
under these conditions (Kulkosky, Gibbs, & Smith, 1982).
In addition, the pattern of behaviors observed after 
central bombesin do not completely duplicate the behaviors 
that follow normal satiety, resting decreases while 
grooming increases (Kulkosky, Gibbs, & Smith, 1982) .
These changes in behavior are not observed after 
peripheral bombesin (Kulkosky, Gibbs, & Smith, 1982).
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The stereotypies produced by central administration 
of bombesin appear to be mediated in part by dopaminergic 
neurons. Increased grooming behavior caused by central 
bombesin can be attenuated by peripheral administration of 
fluphenazine and haloperidol (Moody, Merali, & Crawley, 
1988). Additional support for this theory is found in 
data which demonstrates that bombesin-induced grooming 
abnormalities are abolished by depletion of dopaminergic 
neurons using 6-dihydroxytryptamine (Moody, Merali, & 
Crawley, 1988). In addition to a possible dopaminergic 
axis of bombesin-induced grooming, it is also known that 
the anxiolytics, diazepam and chlordiazepoxide reverse it 
as well, implicating a potential involvement of 
benzodiazepine receptors (Crawley & Moody, 1983; Moody, 
Merali, & Crawley, 1988).
It has been suggested that the excessive grooming 
associated with central bombesin administration may 
represent a behavioral attempt to reduce stress associated 
with activation of the sympathetic nervous system (Crawley 
& Moody, 1983). One of the behavioral effects of central 
bombesin administration is increased locomotion (Pert, 
Moody, Pert, Dewald, & Rivier, 1980). As previously 
described in bombesin-induced grooming, it has been found 
that aberrations in bombesin-induced locomotion can be 
abolished with dopamine antagonists (Pert, Moody, Pert, 
Dewald, & Rivier, 1980). While the exact mechanism by
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which bombesin produces these behavioral changes is not 
known, there appears to be an implication of dopaminergic 
neurons and/or pathways. Interestingly, examination of 
bombesin-induced hypothermia and hypophagia after 
microinjection into the substantia nigra, an area critical 
in dopamine control of motor function, failed to mention 
any abnormalities in grooming or locomotion (Calisher & 
Avery, 1984) .
BOMBESIN AND THERMOREGULATION 
Introduction to Nonshivering Thermogenesis
All mammals are homeothermic, and must maintain their 
internal body temperature within a narrow range so as to 
promote optimal homeostasis. There are a variety of 
factors which impact the regulation of body temperature in 
homeotherms. Because of this, a brief review of 
thermogenic systems and thermoregulatory balance is in 
order.
Several mechanisms provide synergistic effects in the 
regulation of temperature in homeotherms. One primary 
thermoregulatory effector is metabolic thermogenesis. 
Gordon (Gordon, 1990), describes metabolic thermogenesis 
as being comprised of two primary parts. One component is 
shivering thermogenesis, in which generation of heat is 
accomplished by erratic skeletal muscle movements which 
are not under voluntary control (Gordon, 1990). This form 
of thermogenesis occurs when an animal is placed in an 
environment which has an ambient temperature below which 
normal resting metabolism will not produce sufficient heat 
to compensate for heat loss (Gordon, 1990).
A second component of metabolic thermogenesis is 
nonshivering thermogenesis, which is accomplished by 
activation of special brown adipose tissues commonly found 
in the interscapular area in rats (Himms-Hagen, 1984), as 
well as cervical, pericardial, intercostal, and perirenal
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areas (Gordon, 1990). Brown adipose tissue is under 
control of the sympathetic nervous system, and is 
stimulated to produce heat by both direct innervation and 
circulating catecholamines (Landsberg, Saville, & Young,
1984). Norephinephrine released from the sympathetic 
nerves which innervate the brown adipose tissue is the 
primary initiator of heat production in response to 
exposure to temperatures below thermoneutrality (Gordon, 
1990). Nicholls (Nicholls & Locke, 1984), suggests that 
in cold exposure the following events are believed to be 
responsible for acute thermogenesis in brown adipose 
tissue: 1) norepinephrine binds to the beta receptors, 2) 
cyclic adenosine monophosphate levels in the cytosol rise, 
3) a protein kinase is activated, 4) lipase is 
phosphorylated and activated, 5) fatty acids are liberated 
and activated to acylcarnitine, 6) respiratory control 
inhibits the oxidation of acylcarnitine, and the 
acylcarnatine and acetyl coenzyme-A pools fill, 7) free 
fatty acids accumulate, reversing the nucleotide 
inhibition of the 32,000-Mr (uncoupling) protein, 8) 
producing an increased proton conductance which allows 
acylcarnitine to be oxidized, and produces a steady-state 
concentration of fatty acids with a balance between 
lipolysis and oxidation. Another thermoregulatory 
effector is peripheral vasomotor tone. When blood vessels 
dilate in response to cutaneous cooling, a correlated
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increase in metabolism occurs (Gordon, 1990) . This 
vasodilation provides increased circulation to the 
cutaneous tissues resulting in warming of the periphery. 
Vasodilation in ambient temperatures below 
thermoneutrality results in heat dissipation (Gordon,
1987). At temperatures above thermoneutrality, increased 
vasodilation can result in transfer of environmental 
energy into the animal, resulting in hyperthermia (Bruck & 
Zeisberger, 1987).
In addition, evaporative water loss from an organism 
represents another thermoregulatory effector (Gordon,
1990). As water evaporates, surface cooling takes place. 
This type of evaporative loss may be passive, such as in 
the evaporation which takes place under normal 
respiration, or it may be active, as in the case when 
rodents spread saliva on their fur to enhance evaporative 
cooling (Gordon, 1990).
The final and perhaps most common of all 
thermoregulatory effectors is behavioral actions in which 
an animal protects its critical body temperature (Gordon, 
Lee, Chen, Killough, & Ali, 1991). Methods which allow 
animals to behaviorally influence their body temperature 
is the use of gradient chambers (Gordon, Lee, Chen, 
Killough, & Ali, 1991) or operant training for heat 
reinforcement or heat escape (Hawkins & Avery, 1983).
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The event of heat loss or gain can be derived from 
the "heat balance equation" which comes from the First Law 
of Thermodynamics (Gordon, 1990). This equation describes 
the net exchange of heat energy between an organism and 
its environment. When a homeothermic organism is at rest, 
heat balance can be described as: S = M + E + R + C + K  
Where: S = net rate of heat storage; M = metabolic heat 
production; E = net rate of evaporative heat exchange; R = 
net rate of radiant heat exchange; C = net rate of 
convective heat transfer; and K = net rate of conductive 
heat transfer (Gordon, 1990). If heat production exceeds 
heat loss then S is a positive value, and the animals 
becomes hyperthermic, whereas if heat loss exceeds 
production S is a negative value (Gordon, 1990) . A 
condition of thermal equilibrium is reached when heat loss 
and heat production are equal (Gordon, 1990). Thus, 
hypothermia and hyperthermia can be explained in component 
parts. In the heat balance equation only one factor, 
metabolism, accounts for internal heat production while 
several other factors may act simultaneously to contribute 
or detract from heat storage. Under conditions where 
ambient temperatures are below thermoneutrality, these 
other factors generally account for heat loss. At 
temperatures above thermoneutrality these same factors 
contribute to heat gain.
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Bombesin in the Cold-Exposed Rat
Central injections of bombesin produce hypothermia in 
cold-exposed rats (Babcock, Barton, & Keene, 1989; Brown, 
1981; Brown, Rivier, & Vale, 1977; Francesconi & Mager, 
1981; Hawkins & Avery, 1983; Lin & Lin, 1986; Pittman, 
Tache, & Brown, 1980; Rivier & Brown, 1978; Tache,
Pittman, & Brown, 1980; Wakabayashi, Tonegawa, &
Shibasaki, 1983; Wunder, Hawkins, Avery, & Swan, 1980)]. 
Injections of bombesin into the preoptic area of 
hypothalamus have been shown to be effective in producing 
hypothermia in cold-exposed rats (Lin & Lin, 1986;
Pittman, Tache, & Brown, 1980; Wunder, Hawkins, Avery, & 
Swan, 1980). This is an area known to contain 
thermosensitive neurons (Nakayama, 1985), be an important 
site for regulation of core body temperature (Cantor & 
Satinoff, 1976; Satinoff & Rutstein, 1970), and play an 
active role in stimulation of thermogenesis via brown 
adipose tissue (Amir & De Blasio, 1991). It has been 
suggested that bombesin-induced hypothermia in 
cold-exposed rats may represent an inhibition of 
regulatory heat production (Brown, 1981; Brown, Allen, & 
Fisher, 1987; Lin & Lin, 1986). There is also evidence 
that centrally administered bombesin may reduce metabolism 
in the cold-exposed animal. Central bombesin produces a 
reduction in oxygen consumption in cold-exposed rats 
(Brown, 1981; Lin & Lin, 1986; Shido, Noda, & Nagasaka,
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1987; Wunder, Hawkins, Avery, & Swan, 1980), prevents 
increased oxygen consumption associated with cold-exposure 
(Brown, 1982), and impairs the cold-induced increase of 
dopamine accumulation in the interscapular brown adipose 
tissue, but not other tissues, in rats treated with a
dopamine (J-hydroxylase inhibitor (Brown, Allen, & Fisher,
1987). Additionally, bombesin causes hypothermia without 
altering heat loss as measured by cutaneous temperatures 
(Lin & Lin, 1986) .
The exact mechanism by which bombesin induces 
hypothermia at temperatures below thermoneutrality is 
unclear. Findings have established that thyrotropin 
releasing factor, prostaglandin E2, and naloxone reverse 
bombesin-induced hypothermia in cold-exposed animals 
(Brown, Rivier, & Vale, 1977). Additionally, bombesin 
prevents cold-induced secretion of thyrotropin stimulating 
hormone, while not preventing thyrotropin releasing 
factor-induced secretion of thyrotropin stimulating factor 
(Rivier & Brown, 1978). This implicates a pituitary axis 
of bombesin control of thyrotropin stimulating hormone.
Yet, bombesin injected centrally produces hypothermia in 
cold-exposed rats that have been hypophysectomized 
(Rasler, 1983). The latter data would indicate that 
bombesin-induced hypothermia in animals exposed to cold is 
not dependent on centrally mediated release of pituitary 
hormones.
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Given the previously mentioned information about 
bombesin-induced hypothermia in animals tested at 
temperatures below thermoneutrality, it would appear that 
bombesin likely produces hypothermia by interfering with 
compensatory heat production. The agents known to reverse 
bombesin-induced hypothermia under these conditions all 
contribute to increased metabolism. Knowing that energy 
balance is a sum of heat production and heat loss, and 
that bombesin has been repeatedly determined to reduce or 
impair metabolism as measured by oxygen consumption in 
cold-exposed rats, it would appear that bombesin most 
likely produces hypothermia by reducing heat production. 
Yet, there is evidence to the contrary. Bombesin injected 
centrally has been found to increase tail skin 
temperatures in animals at normal ambient temperatures 
(Lin Sc Lin, 1986; Tache, Pittman, Sc Brown, 1980). While 
these findings are not apparent at temperatures below 
thermoneutrality, it does not preclude heat loss as a 
mechanism by which bombesin may induce hypothermia. Tache 
has suggested that bombesin may act to produce hypothermia 
in cold-exposed conditions by essentially making the 
animals poikilothermic, and that change in body 
temperature is dependent upon ambient temperatures (Tache, 
Pittman, Sc Brown, 1980). In support of this are findings 
that bombesin selectively stimulates warm-responsive 
neurons in the preoptic anterior hypothalamic area (Lin Sc
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Lin, 1986). This type of activation of warm-responsive 
neurons would result in vasodilation and other 
physiological changes to promote heat loss (Boulant &
Dean, 1986). Under this type of activity it would seem 
likely that ambient temperature would then influence core 
body temperature. Increased blood flow to cutaneous areas 
would allow for transfer of heat across a gradient. In 
cold-exposed animals heat would be lost to the environment 
while animals tested at temperatures above the upper level 
of thermoneutrality would gain heat. Additionally, 
animals kept at ambient temperatures approximating normal 
body temperatures would not experience a transfer of heat 
energy. This type of thermal exchange in core body 
temperatures has been found to exist in animals 
administered bombesin centrally. Tache and colleagues 
(Tache, Pittman, & Brown, 1980) found that central 
bombesin produced hypothermia in animals tested at an 
ambient temperature of 4° C, hyperthermia at an ambient 
temperature of 3 6° C, and euthermia at an ambient 
temperature of 31° C. Additionally, bombesin treated 
animals which become hyperthermic at temperatures above 
thermoneutrality can be made hypothermic by transfer to a 
cold environment (Tache, Pittman, & Brown, 1980).
It has been suggested that bombesin may alter 
thermoregulatory “set point"; a core body temperature 
established by central mechanisms which an animal will
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attempt to defend (Avery & Calisher, 1982; Wunder,
Hawkins, Avery, & Swan, 1980). Animals trained to bar 
press for heat escape, do so more frequently after central 
bombesin administration (Avery, Hawkins, & Wunder, 1980) . 
Avery reasons that this response is a behavioral attempt 
to protect a lowered thermoregulatory set point. Given 
that bombesin activates warm-responsive neurons, as 
previously demonstrated (Lin & Lin, 1986), then it would 
seem plausible that these animals may "feel" warm, and 
thus bar press to escape heat. In support of this, 
animals administered bombesin centrally have been found to 
select ambient temperatures in gradients significantly 
lower than saline injected animals (Stump, McCoy, & Avery,
1990). Yet, in the case of bar pressing for defense of an 
altered set point, there is contrary data. It has been 
found that adrenalectomy abolishes increased bar pressing 
for heat escape in bombesin treated animals tested at 
temperatures below thermoneutrality (Hawkins & Avery,
1983). Hawkins reasons that bombesin produces an increase 
in behavioral activation secondary to stimulation of the 
adrenal glands. This seems unlikely due to findings that 
central bombesin results in decreased bar pressing for 
food reward (Babcock, Avery, & Maitland, 1985) , If 
bombesin simply increases rewarded behavior, then it would 
follow that this response would be generalized to other 
paradigms, which is not the case. Furthermore,
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adrenalectomy is known to increase thermogenesis in brown 
adipose tissue (Kim & Romsos, 1990). This may have been 
the case as none of the animals tested by Hawkins ever 
actually displayed hypothermia (Hawkins & Avery, 1983).
In fact, adrenalectomized rats did not display any 
differences in heat escape after central bombesin versus 
control treatment (Hawkins & Avery, 1983), which was quite 
probably because they were euthermic.
Provided the previous findings related to 
bombesin-induced hypothermia in animals tested at 
temperatures below thermoneutrality, the underlying 
mechanism is still not proven. There is evidence which 
suggests that central bombesin injections may produce 
hypothermia by activation of brain mechanisms, thereby 
disrupting metabolic processes or increasing heat loss via 
peripheral vasodilation. In addition there is evidence 
that bombesin may alter central mechanisms in a way such 
that an animal displays behaviors that appear to be 
directed toward defense of a lowered core body 
temperature. The possibility that more than one of these 
factors may influence bombesin-induced hypothermia in cold 
environments has not been ruled out.
Bombesin-Induced Hypothermia at 
Normal Ambient Temperatures
Central injection of bombesin was first reported to 
produce hypothermia in rats tested at normal ambient 
temperatures in 1980 (Tache, Pittman, & Brown, 1980) . It 
was later reported that bombesin-induced hypothermia in 
animals tested near thermoneutrality was associated with 
no change in metabolic rate as measured by oxygen 
consumption (Brown, 1981; Wunder, Hawkins, Avery, & Swan, 
1980). While some data exists suggesting that hypothermia 
observed under these conditions is not dependent upon 
manipulation of food intake (Tache, Pittman, & Brown,
1980; Wunder, Hawkins, Avery, & Swan, 1980), others were 
unable to replicate these findings (Avery & Calisher,
1982; Babcock & Barton, 1989; Babcock & Barton, 1990; 
Babcock, Barton, Gunion, & Rosenthal, 1992; Babcock, 
Barton, & Keene, 1989; Babcock, Barton, Perez, & Hearndon, 
1989; Barton & Babcock, 1990; Barton & Hawkins, 19 93; 
Calisher & Avery, 1984). To date, bombesin has been 
reported to produce hypothermia when injected into the 
cerebral ventricles (Avery & Calisher, 1982; Babcock, 
Barton, & Keene, 1989; Babcock, Barton, Perez, & Hearndon, 
1989; Babcock & Wunder, 1984; Francesconi & Mager, 1981; 
Wunder, Hawkins, Avery, & Swan, 1980), the preoptic area 
of the hypothalamus (Babcock, Baker, & Moody, 1992;
Babcock & Barton, 1989; Babcock, Barton, Gunion, &
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Rosenthal, 1992; Babcock, Barton, & Keene, 1989; Babcock & 
Maisel, 1991; Barton & Babcock, 1990), the hypothalamic 
paraventricular nucleus (Babcock & Barton, 1990), and the 
substantia nigra (Calisher & Avery, 1984), of animals 
tested at normal ambient temperatures.
The prevailing theory is that bombesin-induced 
hypothermia in animals tested under normal ambient 
temperatures is dependent on some pre-existing condition, 
which acts as a "permissive" factor for hypothermia to 
occur. Previous data has established that animals acutely 
food-deprived (Avery & Calisher, 1982; Babcock, Baker, & 
Moody, 1992; Babcock, Barton, Gunion, & Rosenthal, 1992; 
Babcock, Barton, & Keene, 1989; Babcock & Wunder, 1984; 
Barton & Babcock, 1990; Calisher & Avery, 1984), injected 
with insulin peripherally (Babcock & Barton, 1989; Babcock 
& Barton, 1990; Babcock, Barton, Gunion, & Rosenthal,
1992; Babcock, Barton, Perez, & Hearndon, 1989; Barton & 
Babcock, 1990), or 2-deoxy-D-glucose (Babcock & Maisel,
1991), or with lesions of the ventromedial hypothalamus 
(Barton & Hawkins, 1993), experience hypothermia when 
injected with bombesin centrally. Exactly how these 
pre-existing conditions contribute to the production of 
bombesin-induced hypothermia at normal ambient 
temperatures remains unclear. It has been theorized that 
one potential condition these manipulations may contribute 
to is reduced peripheral glucose availability (Babcock &
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Maisel, 1991). This appears to be supported by findings 
that bombesin-induced hypothermia seen in animals acutely 
deprived of food or treated with peripheral insulin is 
attenuated by allowing the animals to eat (Barton & 
Babcock, 1990).
Bombesin-induced hypothermia demonstrated at normal 
ambient temperatures is believed to be mediated by 
different mechanisms from those seen in conditions of 
acute cold exposure. Several findings contribute to this 
belief. Unlike bombesin-induced hypothermia observed in 
cold-exposed animals, hypothermia precipitated by bombesin 
at normal ambient temperatures is not attenuated by 
peripheral naloxone (Babcock, Barton, & Keene, 1989). 
Moreover, hypothermia produced by bombesin at normal 
ambient temperatures is not associated with a decrease in 
metabolism (Babcock & Wunder, 1984) , yet conflicting data 
exists (Lin & Lin, 1986; Shido, Noda, & Nagasaka, 1987; 
Tache, Pittman, & Brown, 1980).
The mechanism by which bombesin produces hypothermia 
at normal ambient temperatures is unclear. Lin (Lin &
Lin, 1986), has demonstrated that bombesin-induced 
hypothermia under conditions of normal ambient temperature 
results in reduced oxygen consumption and increased heat 
loss. In opposition to Lin's data, experiments examining 
bombesin-induced heat loss related to hypothermia using 
cutaneous tail temperature failed to support this finding
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(Babcock & Barton, 1989). If bombesin does not alter 
metabolic rate, then some form of heat loss must account 
for the hypothermia produced. In support of this theory 
are findings that the core body temperature of rats 
injected centrally with bombesin drift toward the 
temperature of their environment (Tache, Pittman, & Brown, 
1980). Additional support is found in data which 
establishes that bombesin produces peripheral vasodilation 
(Lin & Lin, 1986). It has also been shown that bombesin 
produces increased evaporative heat loss as measured by 
experiments designed to isolate this parameter via direct 
calorimetry (Shido, Noda, & Nagasaka, 1987).
Thus, given the previous findings, it is clear that 
bombesin can produce hypothermia at normal ambient 
temperatures. Bombesin-induced hypothermia under these 
conditions appears to be reliant upon some manipulation of 
factors related to nutritional status, which have been 
suggested to negatively influence glucose availability. 
Reports that bombesin alters resting metabolic rate out 
number ones that it does not. In addition, there is 
considerable evidence that bombesin promotes heat loss at 
normal ambient temperatures.
The relationship between the permissive events which 
contribute to bombesin-induced hypohtermia at normal 
ambient temperatures is shown in Figure 2. Acute 
food-deprivation or peripheral injection of
51
2-deoxy-D-glucose reduce glucose utilization while having 
little affect on glucose availability. Both peripheral 
injection with insulin or lesions of the ventromedial 
hypothalamus increase utilization but with differential 
affect on availability. Insulin injection reduces 
availability by promoting utilization while lesions of the 
ventromedial hypothalamus increases availability as well 
as utilization. Thus, there is no consistent relationship 
between the necessary pre-existing events which allow 
bombesin-induced hypothermia at normal ambient 
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Bombesin is known to produce a wide spectrum of 
behaviorally and physiologically related effects when 
administered centrally. Previous studies of 
bombesin-induced hypothermia have been conducted under 
conditions of cold-exposure, food-deprivation, insulin 
treatment, 2-deoxy-D-glucose treatment, and lesions of the 
ventromedial hypothalamus. Each of these experimental 
manipulations result in hypothermia following central 
bombesin administration, yet the underlying mechanisms are 
not well understood. The objective of this study was to 
determine if a potential reduction of sympathetic nervous 
system stimulation, brought about by the factors 
previously shown to be permissive events, is responsible 
for bombesin-induced hypothermia at normal ambient 
temperatures.
All of the conditions which have been implicated as 
permissive factors in bombesin-induced hypothermia produce 
reductions in efferent sympathetic nervous system 
activation of interscapular brown adipose tissue. 
Food-deprivation (Dulloo, Young, & Landsberg, 1988; 
Landsberg & Young, 1978; Sakaguchi, Arase, Fisler, & Bray,
1988) and injections of 2-deoxy-D-glucose (Egawa, 
Yoshimatsu, & Bray, 1989; Holt & York, 1989; Landsberg & 
Krieger, 1989) result in decreased norephinephrine 
turnover in brown adipose tissue and reduce firing rates
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of isolated efferent sympathetic nerves that innervate 
brown adipose tissue, as do lesions of the ventromedial 
hypothalamus (Niijima, Rohner-Jeanrenaud, & Jeanrenaud,
1984). Additionally, hyperinsulinemic animals also 
exhibit reductions in norephinephrine turnover in brown 
adipose tissue (Nishioka, Yoshida, Yoshioka, & Kondo, 
3.987). Thus, conditions that permit bombesin-induced 
hypothermia in animals tested at normal ambient 
temperatures, may do so by attenuating the thermogenic 
capacity of brown adipose tissue to compensate for 
peripheral heat loss. This hypothesis receives indirect 
support by findings that bombesin-induced hypothermia is 
attenuated when animals are allowed to eat (Barton & 
Babcock, 1990). Feeding promotes sympathetic nervous 
system activation of brown adipose tissue (Sakaguchi, 
Arase, Fisler, & Bray, 1988) and increased heat production 
(Himms-Hagen, Hogan, & Zaror-Behrens, 1986; Rothwell & 
Stock, 1979; Stock & Rothwell, 1986), as well as its 
growth (Sundin & Nechad, 1983) . Therefore, it seems 
plausible that attenuation of bombesin-induced hypothermia 
in food-deprived or insulin-treated rats allowed to feed 
during testing is mediated by increased thermogenesis in 
the brown adipose tissue, secondary to food consumption.
If reduced sympathetic nervous system stimulation of 
brown adipose tissue is necessary for bombesin-induced 
hypothermia, then ganglionic blockade of the sympathetic
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efferents which innervate brown adipose tissue in rats 
administered bombesin, should result in hypothermia at 
normal ambient temperatures. Chlorisondamine administered 
peripherally acts on nicotinic receptors within the 
sympathetic ganglia to block sympathetic nervous system 
activity and prevent increased thermogenesis (Amir,
1990,a; Amir, 1990,b; Amir, 1990,c; Amir & De Blasio,
1991). In addition, it does not modulate serum glucose 
levels or glucose utilization (Turinsky, 1974).
Therefore, ad-libitum fed rats were injected centrally 
with bombesin and peripherally with chlorisondamine to 
investigate the effect of bombesin on core body 
temperature.
If reductions in sympathetic nervous system 
stimulation to brown adipose tissue allow bombesin to 
produce hypothermia at normal ambient temperatures, then 
stimulation of the brown adipose tissue by way of a 
sympathomimetic, should block bombesin-induced 
hypothermia.' The experimental compound CL-316,243 is a
drug that acts on P3-adrenergic receptors and has been
demonstrated to promote thermogenesis in brown adipose 
tissue (Himms-Hagen et al., 1994). Chronic treatment of 
rats on high fat diets with this compound produces an 
increase in metabolic rate, hypertrophy of brown adipose 
tissue, and a robust increase in uncoupling protein 
(Himms-Hagen et al., 1994). Himms-Hagen (Himms-Hagen et
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al. , 1994), has theorized that CL-316,243 induces an 
increase in total mitochondria in chronic application, 
thereby producing the increase in uncoupling protein. 
Uncoupling protein promotes oxidation of substrate which 
is no longer coupled to adenosine triphosphate synthesis, 
thereby providing a unique source of dissipative heat 
generation in brown adipose tissues (Klingenberg, 1990). 
Thus, peripherally administered CL-316,243 was used to 
block the potential effects of reduced sympathetic 
nervous system activation associated with bombesin-induced 
hypothermia at normal ambient temperatures.
Hypotheses
The following hypotheses will be addressed under the 
proposed experiments:
Hypothesis 1. If reductions in sympathetic nervous system 
activation of brown adipose tissue provide a necessary 
pre-existing condition for bombesin-induced hypothermia in 
animals tested at normal ambient temperatures, then 
ad-libitum fed rats, administered chlorisondamine 
peripherally, should become hypothermic after lateral 
ventricular injections of bombesin.
Hypothesis 2. If reduction in sympathetic nervous system 
activation of brown adipose tissue thermogenesis acts as 
the permissive event for bombesin-induced hypothermia at 
normal ambient temperatures, then CL-316,243 administered
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peripherally should prevent bombesin-induced hypothermia 
in food-deprived and chlorisondamine treated animals 
injected with bombesin into the lateral ventricles.
GENERAL METHODS 
Subjects
In all experiments male Sprague-Dawley rats (300-400 
g) were used. Animals were housed individually in 
standard wire and steel laboratory cages. Animals 
received ad-libitum access to standard laboratory chow 
(Ralston Purina Co.) and water except where mentioned in 
specific experimental designs. Ambient temperatures for 
housing and testing procedures was maintained at 24° C (+ 
2° C). Photopheriod was on a twelve hour schedule with 
onset of the dark-phase at 19:00 hrs.
Surgery
A guide cannulae constructed of 22-gauge 
stainless-steel tubing was implanted into a lateral 
cerebral ventricle of each animal under pentobarbital 
anesthesia (35 mg/Kg body weight, i.p.). After initiation 
of anesthesia animals were placed in a stereotaxic 
instrument (model 900A, David Kopf Instruments, Tujunga, 
CA) and a midline incision made on the superior surface of 
the skull. The skull was trephined and stainless-steel 
anchor screws inserted into the bone. Guide cannulae were 
implanted using stereotaxic coordinates 0.9 mm posterior 
to bregma, 1.5 mm lateral to midline, and 4.0 mm ventral 
to the skull surface (Paxinos & Watson, 1982). Cannulae 
were cemented in place using dental acrylic. A 2 6-guage
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wire obturator was kept in the guide cannula to maintain 
patency except during injections. All animals were 
provided a 7-10 day post-surgical recovery period prior to 
experimentation.
Adrenalectomy was performed under pentobarbital 
anesthesia (35 mg/Kg body weight, i.p.). After initiation 
of anesthesia, the surgical area was prepared and 
incisions parallel to the spine, caudal to the back 
muscles, and immediately posterior to the rib cage were 
made. In the event of complete bilateral adrenalectomy, 
exploration and isolation of the adrenals was accomplished 
using curved forceps. The adrenal glands were removed by 
blunt dissection and the muscle and skin closed using 
interrupted sutures. In sham adrenalectomized subjects, 
the adrenals were visualized and the incisions were 
sutured closed. Following surgery all animals were 
allowed a 7-10 day recovery period and were maintained on 
sterile 0.9% saline drinking solution in place of tap 
water.
Drugs
Anhydrous bombesin (Research Biologicals Inc., CA)
was diluted with 0.9% sterile saline (100 ng/5.0 |il) for
icv administration. Injections were be made using a 
26-guage injector cannula designed to extend 1.0 mm beyond 
the ventral aspect of the guide cannula. The injector
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cannula was connected to a 100 Hi syringe by sterile
polyethylene tubing. Injection volumes (5.0 |ll) were
infused over a 1 minute period of time using a motor 
driven infusion pump (Harvard Apparatus,South Natick, MA) .
Anhydrous chlorisondamine HC1 (CIBA Pharmaceuticals, 
Summit, NJ) were diluted with 0.9% sterile saline (2.5 
mg/1 ml) for i.p. injection. Anhydrous CL-316,243 
(American Cyanamid, Wayne, NJ) was diluted with 0.9% 
sterile saline (1.0 mg/1 ml) for i.p. injection. 
Crystalline corticosterone (ICN Biomedicals, Costa Mesa, 
CA) was dissolved in polyoxyethylenesorbitan monolaurate 
(Tween 20) (Sigma, St. Louis, MO) and then diluted with 
sterile saline in a 1:5 ratio (0.1 mg/ ml). Peripheral 
injections were made using a 1 ml syringe and 26-guage 
hypodermic needle.
Cannulae Verification
At the completion of testing, animals were sacrificed 
by carbon dioxide euthanasia. An injector was placed into
the guide cannula and a 5.0 |il volume of India ink
infused. Brains were removed from craniums and coronal 
sections made to examine the ventricles for ink infusion. 
Only data coming from those animals having ink infusion 




Data was evaluated using analysis of variance (ANOVA) 
using the computer program SigmaStat (Jandel Scientific, 
San Rafael, Ca). Differences between group means were 
analyzed using Newman-Keuls post hoc test.
EXPERIMENT I 
Introduction
Bombesin-induced hypothermia in animals tested at 
normal ambient temperatures appears to require an 
antecedent event(s) which has been linked to reduction in 
sympathetic stimulation of brown adipose tissue. The 
importance of brown adipose activity in the induction of 
bombesin-induced hypothermia is unknown. This study 
evaluated core body temperature using peripheral 
chlorisondamine injections to block ganglionic innervation 
of the brown adipose tissue prior to central bombesin 
administration in ad-libitum fed rats.
Procedure
Beginning at 09:30 animals were removed from their 
cages and core body temperatures were measured by 
inserting a thermistor probe (Harvard Apparatus, South 
Natick, MA) 6.5 cm beyond the anal orifice. Immediately 
after recording temperatures each animal was injected with 
either chlorisondamine (2.5 mg/kg) or saline, and returned 
to its cage. Thirty minutes after peripheral injection 
the animals were again removed from their cages, core body 
temperatures recorded, received central injection of
either bombesin (100 ng/5.0 |il, icv) or saline vehicle
(5.0 }ll), and then returned to their cages. After 60 
minutes had elapsed from central injection, core body
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temperature was recorded to evaluate potential 
hypothermia. A between-group design was utilized 
resulting in four groups: (central/peripheral) 
saline/saline, bombesin/saline, bombesin/chlorisondamine, 
and saline/chlorisondamine (n=7 per group).
Results
Change in core body temperature defined as the 
difference from preinjection levels are shown in Figure 3. 
Two-way repeated measures ANOVA demonstrated a significant 
effect of treatment condition on core body temperature 
[F(3,48)=12.897, p<0.001], as well as a significant effect 
of time of recording on core body temperature 
[F(2,48)=24.851, p<0.001]. Additionally, there was a
significant interaction between treatment condition and 
time [F(6,48)=20.033, p<0.001]. Newman-Keuls post hoc 
testing revealed that body temperature did not differ 
significantly between groups as a function of peripheral 
injection alone, and that only animals receiving the 




























BEFORE AFTER (60 min)
CENTRAL INJECTION
Figure 3. Change in core temperature in ad libitum fed 
rats treated with bombesin and chlorisondamine. BEFORE, 
represents change in core temperature at time of central 
injection (30 min post peripheral injection). AFTER, 
represents change in core temperature at termination of 
experiment (60 min post central injection). Legend 
indicates central/peripheral treatment [bombesin (BOM) 100 
ng/5n.l, icv; chorisondamine (CHL) 2.5 mg/kg, ip; vehicle 
(SAL)]. Bars indicate standard error of the mean. *p<
0.05 vs SAL/SAL control condition.
EXPERIMENT II 
Introduction
Experiment I indicates that bombesin-induced 
hypothermia occurs in ad-libitum fed animals treated with 
the nicotinic ganglionic receptor blocker,
chlorisondamine. It is hypothesized that this hypothermia 
is secondary to attenuation of sympathetic drive to brown 
adipose tissue. This study examines the hypothesis that 
direct activation of thermogenesis in brown adipose 
tissue, in animals which have received chlorisondamine, 
can attenuate bombesin-induced hypothermia. This was 
accomplished using peripheral injections of the
(33-adrenergic agonist, CL-316,243.
Procedure
Beginning at 09:30 animals were removed from their 
cages and core body temperatures were measured by 
inserting a thermistor probe 6.5 cm beyond the anal 
orifice. Immediately after recording temperatures each 
animal was injected with either chlorisondamine (2.5 
mg/kg) and saline, or chlorisondamine (2.5 mg/kg, ip) and 
CL-316,243 (1 mg/kg, ip) and returned to its cage. Thirty 
minutes after peripheral injections the animals were 
removed from their cages, core body temperatures recorded, 
were administered central injection of either bombesin
(100 ng/5.0 [ll, icv) or saline vehicle (5.0 |ll), and then
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returned to their cages. After 60 minutes had elapsed 
from central injection, the core body temperature was 
recorded to evaluate potential hypothermia. A 




bombesin/chlorisondamine+CL-316, 243 , (n=7 per group).
Results
Change in core body temperature after treatment with 
bombesin and CL-316,243 is shown in Figure 4. Two-way 
repeated measures ANOVA indicated a significant effect of 
treatment condition on core body temperature 
[F(3,72)=4.05, p<0.01], time of temperature recording on 
core body temperature [F(2,72)=8.26, p<0.001], and 
interaction between treatment condition and time of 
temperature recording [F(6,72)=3.93 , p<0.001].
Newman-Keuls post hoc testing indicates that core body 
temperature did not differ between groups as a function of 
peripheral injection alone. The only group that 
demonstrated significant hypothermia was the one that 
received chlorisondamine + saline peripherally, and 
bombesin centrally. Peripheral injection of CL-316,243 
prevented hypothermia in animals receiving central 


























BEFORE AFTER (60 min)
CENTRAL INJECTION
Figure 4. Change in core temperature in ad libitum fed 
rats following central bombesin and peripheral 
chlorisondamine and CL-316,243. BEFORE, represents change 
in core temperature at time of central injection (30 min 
post peripheral injection). AFTER, represents change in 
core temperature at termination of experiment (60 min post 
central injection). Inset legend indicates 
central/peripheral treatment [bombesin (BOM) 100 ng/5|ll, 
icv; chlorisondamine (CHL) 2.5 mg/kg, ip; CL-316,243 
(CL)l.O mg/kg; ip; vehicle (SAL)]. Bars indicate standard 
error of the mean for each condition and time point.
*p < 0.05 vs SAL/CHL+SAL control condition.
EXPERIMENT III 
Introduction
Previous studies have demonstrated that 
bombesin-induced hypothermia occurs in acutely 
food-deprived animals tested at normal ambient 
temperatures (Avery & Calisher, 1982; Babcock, Baker, & 
Moody, 1992; Babcock, Barton, Gunion, & Rosenthal, 1992; 
Babcock, Barton, & Keene, 1989; Babcock & Wunder, 1984; 
Barton & Babcock, 1990; Calisher & Avery, 1984). Acute 
food deprivation is known to result in reduced sympathetic 
nervous system drive to brown adipose tissue (Sakaguchi, 
Arase, Fisler, & Bray, 1988) but not produce hypoglycemia 
(Barton & Babcock, 1990). Experiment II demonstrated that
the P3-adrenergic sympathomimetic CL-316,243 prevents
bombesin-induced hypothermia in ad-libitum fed rats 
treated with chlorisondamine, most likely by direct 
stimulation of thermogenesis in brown adipose tissue.
This experiment will examine if food-deprivation produces 
a permissive event in bombesin-induced hypothermia by 
reducing sympathetic stimulation of brown adipose tissue 
and if alteration of serum glucose is important in this 
event. If suppression of sympathetic nervous system 
activity is the pivotal mechanism in bombesin-induced 
hypothermia, then peripheral injections of CL-316,243 




Animals were food-deprived 20 hours prior to central 
injections except for a single control group (n=5). 
Techniques utilized for recording core body temperature 
and animals handling are identical to those detailed in 
Experiment I. Core body temperature was recorded at 3 0 
minutes prior to central injection (beginning at 0930), at 
the time of central injection, and 30 and 60 minutes post
central injection. Peripheral injections consisted of
either saline, or CL-316,243 (1 mg/Kg, i.p.). Central 
injections consisted of either bombesin (100 ng/5.0 ul, 
icv) or saline (5.0 ul). A between-group design was 
utilized resulting in the following drug treatment groups 
at specific times: (condition time relative to central injection) ad
libitum fed_30, f ood-deprived_30, food-deprived+i .p. saline0, 
food-deprived+i .p. CL-316,2430, icv saline+i.p. saline30, 
icv saline+i.p. CL-316, 24330, icv bombesin+i . p . saline30, 
icv bombesin+i .p.CL-316,24330, icv saline+i.p. saline60, icv 
saline+i.p. CL-316, 24360, icv bombesin+i . p . saline60, icv 
bombesin+i.p. CL-316 , 24360. This resulted in 12 groups of
animals (n=5 per group). This design can be seen in
Table 1.
Blood samples were collected by decapitation of live 
animals and draining trunk blood into sterile test tubes 
in an ice chilled container. The blood was centrifuged at 
3500 rpm for 5 minutes using a TRIAC centrifuge, model
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Table 1: Matrix of Test Conditions; Experiment III






Matrix of test conditions. Rows represent treatment 
conditions (central/peripheral). Lower 4 rows represent 
food-deprivation (20 hr) prior to testing. Columns 
represent time of data collection relative to central 
injection. Group data from subjects prior to central or 
peripheral injection(CON) depicted in far left column. Each 
cell represents an experimental group (n = 5/group).
Groups experienced temperature data collection for all time 
points to the left of, and including the column of listing.
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number 0200 (Clay Adams, Parsippany, NJ). The supernatant 
was collected and stored at -70° C until assay. Glucose 
assays were performed using the Beckman CX5 UV-hexokinase 
method in the Clinical Research Laboratory, Pennington 
Biomedical Research Center, Baton Rouge, LA.
Results
Change in core body temperature secondary to 
treatment condition and time are shown in Table 2.
Analysis of variance indicate that there is a significant 
effect of treatment condition on core body temperature 
[F(ll,48)=21.8, p< 0.0001]. Newman-Keuls post hoc testing 
demonstrated that only the group which received bombesin 
centrally and saline peripherally became hypothermic, that 
they were more hypothermic at 60 minutes after central 
injection than at 30 minutes, and that peripheral 
injection with CL-316,243 prevented bombesin-induced 
hypothermia at both time points. Additionally, a two-way 
repeated measures ANOVA performed on the four groups which 
progressed through all temperature measurement points 
demonstrated a significant effect of, treatment condition 
on core body temperature [F(3,48)=18.3 , p<0.0001], as well 
as on time of recording [F(3,48)=34.3, p<0.0001], and 
interaction between treatment condition and time or 
recording [F(9 , 48)=20.8, p<0.0001]. The change in core 
temperature in these groups can be seen in Figure 5.
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Table 2: Core Body Temperature for Treatment Groups
Relative to Injection Time and Condition.
Condition - 30 min 0 min + 30 min + 60 min
CON 38.2±0.139
FD CON 38.4±0.121
FD -/SA L 38.2+0.164
FD - /CL 38.0±0.226
FD SAL/SAL 37.8±0.27 37.9±0.213
FD SAL/CL 38.1±0.178 38.0±0.124
FD BOM/CL 37.8+0.279 38.1±0.233
FD BOM/SAL *36.1+0.275 **34.5+0.499
Lower 7 rows (FD) represents food-deprivation (20 hr) prior 
to testing. Treatment conditions (central/peripheral):
SAL= saline, BOM = bombesin, CL = CL-316,243, CON = groups 
which received no injections. Each cell represents an 
experimental group (n = 5/group) (°C+SEM) . *p<0.05 from all
other conditions. **p<0.05 from BOM/SAL condition at 30 
min.
73
Data from glucose analysis can be seen in Table 3. 
One-way ANOVA on glucose data revealed that there was a 
significant effect of sample condition on glucose levels 
[F(ll,48)=13.798, pcO.OOl]. Newman-Keuls post hoc testing 
revealed that groups receiving saline centrally and 
CL-316,243 peripherally had significantly lower serum 
glucose levels than all other groups. Rats which were 
acutely deprived of food had glucose levels no different 
from animals allowed ad libitum access to food. 
Additionally, central injection of bombesin prevented the 





























0 MIN 30 MIN 60 MIN
TIME FROM CENTRAL INJECTION
Figure 5. Change in core temperature in acutely fasted 
rats following central bombesin and peripheral CL-316,243. 
Abscissa categories indicate change in temperature 
collection relative to time of central injection (0, 30, 60 
min). Inset legend indicates central/peripheral treatment 
[bombesin (BOM) 100 ng/5 |il, icv; CL-316,243 (CL) 1 mg/kg, 
ip; vehicle (SAL)]. Bars indicate standard error of the 
mean for each condition and time point.
*p< 0.05 vs SAL/SAL control condition.
**p< 0.05 vs BOM/SAL condition at 30 min.
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Table 3: Mean Serum Glucose Levels for Treatment Groups
Relative to Injection Time and Condition.
Condition - 30 min 0 min + 30 min + 60 min
ad-lib fed 142.2±3.02
food-deprived 151.0±2.7
FD SAL/CL * 60.8±1.94 * 72.6±5.1 * 79.0±2.39
FD SAL/SAL 130±3.99 121.2±2.96 112.4±1.33
FD BOM/SAL 141.4±10.5 150.2±16.8
FD BOM/CL 122.0±13.62 109.6±12.7
Serum glucose levels (mg/DL + SEM) for treatment conditions 
at time points relative to central injection (columns). 
Treatment conditions (central/peripheral): SAL = saline,
BOM = bombesin, CL = CL-316,243. Prefix FD represent data 
from rats food-deprived (20 hr) prior to treatment 
conditions. *p<0.05 from ad-lib fed controls.
EXPERIMENT IV 
Introduction
The sympathetic nervous system can modulate serum 
glucose levels by neural innervation of the adrenal
medulla (Clutter, Rizza, Gerich, & Cryer, 1988) .
Hypothalamic stimulation of the sympathetic nervous system 
causes the production and release of epinephrine, which in 
turn causes release of glucose from the liver (Guyton,
1991). Stress is known to increase the release of
corticosterone in rats (Mormede et al., 1990) and
elevations in corticosterone levels are known to suppress 
sympathetic nervous system activation of brown adipose 
tissue (Davidovic, Vasilev, & Stojanovic-Susulic, 1992).
In addition, central bombesin administration produces 
hyperglycemia secondary to stimulation of release of 
epinephrine from the adrenal medulla (Brown, Tache, & 
Fisher, 197 9). Previous experiments have demonstrated 
that adrenalectomized animals become hypothermic after 
central bombesin under conditions of food-deprivation 
(Barton, unpublished) but, confirmation of adrenalectomy 
was not performed. Thus, the contribution of adrenal 
products, specifically epinephrine, on bombesin-induced 
hypothermia at normal ambient temperatures is unknown.





Animals were food-deprived 2 0 hours prior to central 
injections. Adrenalectomized animals received 
corticosterone replacement (0.1 mg/kg, s.q.) (Tempel, 
McEwen, & Leibowitz, 1992) while sham adrenalectomized 
animals received vehicle injections (1.0 ml/kg, s.q.) at 
0500 each day after peripheral surgery. All animals were 
maintained on saline drinking solution. Techniques 
utilized for recording core body temperature and animals 
handling are identical to those detailed in Experiment I. 
Core body temperature was recorded at the time of central 
injection and 60 minutes post central injection. This 
resulted in a between-subjects design with three 
experimental groups tested under the following conditions: 
(surgical treatment+central injection/peripheral 
injection) sham adrenalectomy+vehicle/vehicle, 
sham adrenalectomy+bombesin/vehicle, and 
adrenalectomy+bombesin/corticosterone (n=7 per group).
Immediately following the last data collection period 
animals were sacrificed and trunk blood collected in ice 
chilled test tubes. Serum was collected and stored as 
described in Experiment III. Confirmation of complete 
adrenalectomy was established by serum aldosterone assay. 
Aldosterone assays were performed using Aldosterone-MAIA 
in vitro radioimmunoassay diagnostic kits (CIBA-Corning 
Diagnostics Corp., East Walpole, MA), in the Clinical
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Research Laboratory, Pennington Biomedical Research 
Center, Baton Rouge, LA. The criterion for complete 
adrenalectomy was serum aldosterone levels below 5 pg/ml.
Results
Figure 6 depicts changes in core body temperature 
after bombesin treatment in food-deprived rats with and 
without adrenalectomy. Analysis of data using two-way, 
repeated measures ANOVA demonstrated a significant effect 
for treatment condition [F(2,18)=26.9, p<0.0001], time of 
recording [F(l,18)=161.9, p<0.0001], and interaction 
between the two [F(2,18)=88.8, p<0.0001]. Newman-Keuls 
post hoc testing revealed that food-deprived animals 
became hypothermic 60 minutes after central bombesin 
injection with or without adrenalectomy, and that 
adrenalectomized animals were significantly more 


























TIME FROM CENTRAL INJECTION
Figure 6. Change in core body temperature in acutely 
fasted rats following central bombesin with and without 
adrenalectomy. Inset legend indicates peripheral surgical 
treatment + central injection/peripheral injection [sham 
adrenalectomy (SADX); adrenalectomy (ADX); bombesin (BOM) 
100 ng/ 5(il, icv; corticosterone (CORT) 0.1 mg/kg, sc; 
vehicle (VEH)]. Bars indicate standard error of the mean.
* p< 0.05 vs SADX+VEH/VEH control condition. ** p< 0.05 vs 
SADX+BOM/VEH condition.
DISCUSSION
The four experiments conducted in this dissertation 
provide robust evidence that bombesin produces hypothermia 
in rats tested at normal ambient temperatures under 
conditions in which the normal reflex sympathetic 
activation of brown adipose tissue thermogenesis is 
blunted. In Experiment I, it was proven that 
bombesin-induced hypothermia could be produced under 
conditions of ad-libitum access to food by using the 
ganglionic blocker chlorisondamine. Chlorisondamine is 
known to act peripherally to prevent activation of brown 
adipose tissue thermogenesis by suppressing sympathetic 
drive (Amir, 1990,a; Amir, 1990,b; Amir, 1990,c; Amir & De 
Blasio, 1991). Additionally, chlorisondamine does not 
effect serum glucose levels or glucose utilization 
(Turinsky, 1974). Data from Experiment II demonstrates 
that bombesin produces hypothermia when administered 
centrally to ad-libitum fed rats treated peripherally with 
chlorisondamine, as in Experiment I, and that this 
hypothermia is prevented by addition of peripheral
treatment with the P3-receptor agonist, CL-316,243. The
sympathomimetic, CL-316,243 is known to act selectively on
P3-adrenergic receptors (Bloom et al., 1992) which are
found primarily in adipose tissues, and produce
thermogenic responses when activated (Himms-Hagen et al. ,
1994). In Experiment III, central bombesin injection
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produced hypothermia in acutely food-deprived rats tested 
at normal ambient temperatures, confirming previous 
reports (Avery & Calisher, 1982; Babcock, Baker, & Moody, 
1992; Babcock, Barton, Gunion, & Rosenthal, 1992; Babcock, 
Barton, & Keene, 1989; Babcock & Wunder, 1984; Barton & 
Babcock, 1990; Calisher & Avery, 1984), and this 
hypothermia was prevented by peripheral treatment with 
CL-316,243. In addition, serum glucose data from 
Experiment III establishes that peripheral treatment with 
CL-316,243 produces hypoglycemia relative to food-deprived 
animals receiving saline control treatment or ad-libitum 
fed rats, and that central bombesin attenuates this 
hypoglycemia. Experiment IV demonstrated that bombesin 
produces hypothermia in acutely food-deprived 
adrenalectomized rats with corticosterone replacement, and 
in sham adrenalectomized rats. Furthermore, after central 
bombesin treatment adrenalectomized rats with 
corticosterone replacement became significantly more 
hypothermic than sham adrenalectomized rats. This 
implicates adrenal catecholamines, and possibly 
corticotrophin-releasing hormone, in modulation of this 
phenomenon.
Previous reports of bombesin-induced hypothermia at 
normal ambient temperatures have been associated with some 
type of pre-existing condition, which had to be present 
for hypothermia to be expressed. Early work by Avery
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(Avery & Calisher, 1982), discovered bombesin-induced 
hypothermia in food-deprived rats tested at normal ambient 
temperatures incidentally, as it was not the main 
objective of their study. They hypothesized that bombesin 
may produce hypothermia in food-deprived rats secondary to 
a change in nutritional state, possibly due to a depletion 
of metabolic fuels (Avery & Calisher, 1982). This 
hypothesis appeared to spawn increased interest in altered 
nutritional conditions which might contribute to 
bombesin-induced hypothermia at normal ambient 
temperatures. Examination of possible metabolic 
suppression by bombesin revealed that in food-deprived 
rats there is no change in oxygen consumption associated 
with development of hypothermia at normal ambient 
temperatures (Babcock & Wunder, 1984). Babcock (Babcock & 
Barton, 1989; Babcock & Barton, 1990; Babcock, Barton, 
Gunion, & Rosenthal, 1992; Babcock, Barton, & Keene, 1989; 
Babcock, Barton, Perez, & Hearndon, 1989; Barton &
Babcock, 1990), demonstrated that bombesin produces 
hypothermia in ad-libitum fed rats tested at normal 
ambient temperatures if first injected peripherally with 
insulin. He believed that peripheral injections of 
insulin simulated the fasted state by producing 
hypoglycemia and stimulating feeding. Later reports 
showed that bombesin-induced hypothermia could be 
exhibited in ad-libitum fed rats if first treated with
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peripheral 2-deoxy-D-glucose (Babcock & Maisel, 1991) or 
if they had lesions of the ventromedial hypothalamus 
(Barton & Hawkins, 1993). Babcock has suggested that 
bombesin-induced hypothermia in ad-libitum fed animals 
treated with 2-deoxy-D-glucose may be secondary to a 
reduction of glucose utilization (Babcock & Maisel, 1991), 
or in the case of insulin treatment, glucose availability 
(Babcock & Barton, 1990). Superficially, this appears to 
be supported by findings that allowing animals to eat 
during testing attenuated bombesin-induced hypothermia 
(Barton & Babcock, 1990). Furthermore, examination of 
serum metabolic fuels seemed to reinforce this concept, as 
that serum glucose levels declined secondary to insulin 
treatment in ad-libitum fed rats made hypothermic with 
bombesin (Babcock, Barton, Gunion, & Rosenthal, 1992).
While the idea that reduced glucose availability or 
utilization may act in some way to allow bombesin to 
produce hypothermia, it seems inadequate in providing any 
concrete mechanism by which it would produce this event. 
York and Bray (personal communication), upon reviewing the 
findings of reports on bombesin-induced hypothermia at 
normal ambient temperatures, suggested an alternative 
mechanism through which the permissive events might 
influence this phenomenon. Their observation was, that 
all conditions which contribute to bombesin-induced 
hypothermia at normal ambient temperatures are also
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associated with reduced sympathetic nervous system 
activation of thermogenesis. This observation became the 
nucleus for the development of the hypothesis that 
bombesin-induced hypothermia in animals tested at normal 
ambient temperatures is dependent upon a pre-existing 
state of suppressed sympathetic nervous system drive to 
brown adipose tissue. Previous studies provide 
significant support for this supposition. Acute 
starvation which permits bombesin-induced hypothermia 
(Babcock, Baker, & Moody, 1992; Babcock & Wunder, 1984; 
Calisher & Avery, 1984), also results in decreased 
norephinephrine turnover in brown adipose tissue (Dulloo, 
Young, & Landsberg, 1988; Landsberg & Young, 1978) as well 
as reductions in sympathetic nervous system drive 
(Sakaguchi, Arase, Fisler, & Bray, 1988). Treatment with 
2-deoxy-D-glucose that allow bombesin-induced hypothermia 
(Babcock & Maisel, 1991), are also known to suppress 
sympathetic nervous system activity (Egawa, Yoshimatsu, & 
Bray, 1989; Landsberg & Krieger, 1989). Ad-libitum fed 
animals made hyperinsulinemic will become hypothermic 
following central bombesin (Babcock & Barton, 1989;
Babcock & Barton, 1990; Babcock, Barton, Gunion, & 
Rosenthal, 1992; Barton & Babcock, 1990; Babcock, Barton, 
Perez, & Hearndon, 1989), and hyperinsulinemia also 
suppresses norephinephrine turnover in brown adipose 
tissue (Nishioka, Yoshida, Yoshioka, & Kondo, 1987).
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Lesions of the ventromedial hypothalamus not only allow 
bombesin-induced hypothermia in ad-libitum fed rats 
(Barton & Hawkins, 1993), but are also known to suppress 
sympathetic efferent firing rates of nerves which 
innervate brown adipose tissue (Niijima,
Rohner-Jeanrenaud, & Jeanrenaud, 1984). Furthermore, the 
act of feeding which attenuates bombesin-induced 
hypothermia (Barton & Babcock, 1990), also promotes heat 
production (Himms-Hagen, Hogan, & Zaror-Behrens, 1986; 
Rothwell & Stock, 1979; Stock & Rothwell, 1986) and 
increases firing rates of sympathetic nerves innervating 
brown adipose tissue (Sakaguchi, Arase, Fisler, & Bray, 
1988). Thus, all conditions which promote 
bombesin-induced hypothermia are directly linked to 
suppression of sympathetic nervous system activation of 
thermogenesis. Additionally, those which attenuate 
bombesin-induced hypothermia are also linked to increased 
sympathetic nervous system activation of thermogenesis.
The potential modulatory effects on glucose 
utilization by adrenal catecholamines in bombesin-induced 
hypothermia is addressed by findings from Experiment IV.
It is known that elevated adrenal epinephrine release
limits glucose utilization by activation of a and 
P-adrenergic receptors (Cryer, 1992). Epinephrine 
activation of a-adrenergic receptors results in inhibition
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of insulin release and promotes hyperglycemia (Clutter, 
Rizza, Gerich, & Cryer, 1988) . In addition, activation of
p-adrenergic receptors by epinephrine adds a synergism to
this phenomenon by stimulating glucagon secretion, hepatic 
glycogenolysis, and gluconeogenesis (Skikama & Ui, 1975). 
Bombesin itself, produces marked increases in epinephrine 
after central administration (Brown, Carver & Fisher,
1988; Brown & Fisher, 1984). In addition, bombesin is 
known to produce hyperglucagonemia and hypoinsulinemia 
(Brown, Tache, & Fisher, 1979). Hyperglycemia following 
icv bombesin injection is eliminated by adrenalectomy, 
suggesting that bombesin acts through neural activation of 
the adrenals to produce this event. Given the data from 
Experiment IV, as well as these other findings, it appears 
that decreased glucose utilization is inadequate as an 
explanation for bombesin-induced hypothermia, especially 
in light of the fact that bombesin itself generates 
changes conducive to reduced glucose utilization. This is 
supported by findings that bombesin-induced hypothermia 
occurs in ad-libitum fed animals after peripheral 
injections of insulin, since insulin actually promotes 
increased glucose utilization (Cryer, 1992).
The data collected from the four experiments detailed 
here, along with previous findings provide overwhelming 
evidence that bombesin-induced hypothermia is mediated by 
sympathetic nervous system activity. This hypothesis is
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efficaciously depicted in Figure 7. Bombesin acts on 
central sites, most likely the preoptic area, to stimulate 
peripheral vasodilation which results in heat loss. Under 
normal food-sated conditions, this does not result in 
hypothermia because of reflex activation of thermogenesis 
by the sympathetic nervous system. When animals are under 
conditions of acute starvation, peripheral injection of 
insulin or 2-deoxy-D-glucose, or have lesions of the 
ventromedial hypothalamus, the reflex sympathetic 
activation of thermogenesis is prevented at the level of 
the central nervous system, and hypothermia results. In 
bombesin-induced hypothermia in ad-libitum fed rats 
injected peripherally with chlorisondamine, the blockade 
of sympathetic activation of thermogenesis occurs at the 
level of the peripheral ganglia. When bombesin-induced 
hypothermia seen in food-deprived or
chlorisondamine-treated rats is prevented by peripheral 
injection with CL-316,243, thermogenesis is restored
secondary to direct stimulation of the P3-adrenergic
receptor in the brown adipose tissue.
Bombesin may have developed as an evolutionary 
process in homeotherms acting as an integrative mechanism 
to dissipate increased heat secondary to feeding related 




Figure 7. Hypothesis that bombesin-induced hypothermia is 
dependant on suppression of sympathetic nervous system 
activity.
nutrient ingestion induces sympathetic nervous system 
activation of thermogenesis via activation of the brown 
adipose tissues (Himms-Hagen, Hogan, & Zaror-Behrens,
1986; Rothwell & Stock, 1979; Sakaguchi, Arase, Fisler, & 
Bray, 1988; Stock & Rothwell, 1986). It is known that 
ingestion of food stimulates release of the mammalian 
counterpart to bombesin, gastrin-releasing peptide, both 
in the periphery, and in the central nervous system (Kateb 
& Merali, 1992). Thus, it is possible that as a mammal 
consumes food, the gastrin-releasing peptide levels 
increase as does production. This may result in increased 
vasodilation and heat loss as a compensatory mechanism to 
thermogenesis. At the same time, it acts as a negative 
feedback signal to the actual consumption of food. In 
this event, hypothermia would not occur since sympathetic 
activation of thermogenesis is probably more than adequate 
to offset the heat loss caused by peripheral vasodilation. 
A simplistic pictorial representation of this theory can 
be seen in Figure 8.
Conclusions
1. Bombesin-induced hypothermia at normal ambient 
temperatures is dependent upon a pre-existing state of 
















Figure 8. Theory of bombesin as an integrative peptide in 
coregulation of temperature and feeding.
2. Bombesin-induced hypothermia seen at normal ambient 
temperatures is not directly related to serum glucose 
levels associated with the fasted state alone.
3. Peripheral activation of thermogenesis, specifically 
in brown adipose tissue, prevents bombesin-induced 
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